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THE RELATIONSHIP BETWEEN MODIFIABLE LIFESTYLE FACTORS AND 
MUSCLE LIPID DEPOTS IN OLDER ADULTS 
 
Muscle health declines with age, influencing both muscle strength and 
performance. Modifiable lifestyle factors may mitigate muscle dysfunction by 
altering muscle lipid depots. Vitamin D status, dietary intake, and physical activity 
each play a role in muscle health during aging. Low vitamin D status (measured 
as 25(OH)D) is prevalent among older adults and has been associated with 
functional limitations and impaired physical performance. Previously, 25(OH)D 
concentrations were inversely associated with extramyocellular lipid (EMCL) and 
our lab observed a significant positive relationship between 25(OH)D 
concentrations and IMCL. Studies have shown mixed results regarding the 
effects dietary fat intake interventions have on muscle lipid depots. It is well 
established that exercise contributes to improved muscle health, but to date 
studies have not examined the relationship between daily physical activity levels, 
muscle lipid depots, and local muscle tissue hemodynamics. We used novel non-
invasive technology to measure gastrocnemius muscle lipid depots (Proton 
Magnetic Resonance Spectroscopy) and monitor local muscle tissue 
hemodynamics during a foot plantar flexion exercise (Near Infrared/Diffuse 
Correlation Spectroscopy). The first aim was to further elucidate the relationship 
between 25(OH)D concentrations, physical function, and muscle lipid depots. We 
also examined 25(OH)D concentrations and muscle lipid depots differences in 
older adults with varied body mass index (BMI) and physical activity levels. We 
observed a negative relationship between 25(OH)D concentrations and EMCL. In 
females, greater 25(OH)D concentrations and lower EMCL were significant 
predictors of faster Four Square Step Test times, independent of BMI and age. 
Greater EMCL and IMCL content were observed with increased BMI, but 
statistical significance was not reached. The second aim was to retrospectively 
examine the relationship between dietary fat intake and muscle lipid depots in 
participants enrolled in a double-blinded placebo-controlled trial. We also 
investigated the relationship between physical activity levels and local muscle 
tissue hemodynamics. Increased dietary fat intake ratio of polyunsaturated to 
 
 
saturated fatty acids (PUFA:SFA) and study intervention (7 days of aerobic 
training) were the best predictors of lower IMCL content, independent of age, 
BMI, and physical activity. Compared with individuals with lower physical activity 
levels, individuals that reported greater physical activity had lower relative blood 
flow and relative oxygen consumption during and after a foot plantar flexion 
exercise. Together these findings suggest that increased physical activity, 
consumption of greater PUFA:SFA, and maintenance of sufficient 25(OH)D 
concentrations may have favorable effects on muscle lipid depots and contribute 
to the preservation of muscle health.  
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Chapter 1: Background 
1.1 Vitamin D: Overview 
Vitamin D is a fat-soluble secosteroid, traditionally associated with bone 
health [1, 2]. Vitamin D has existed on the Earth for at least 500 million years and 
caused a 270-year scientific inquiry for the cure of rickets, a disease first 
recognized in the 1650s [2]. The rickets epidemic emerged during the Industrial 
Revolution, in temperate zones, where the pollution from factories blocked the 
sun’s ultraviolet rays (UV) [2]. By the late 19th and early 20th century, rickets, the 
incomplete calcification of the epiphyseal closure in children [3], affected more 
than 80% of children living in United States’ and European cities [4]. While some 
cases of rickets are related to hereditary syndromes, renal disease, or use of 
medication, outbreaks of rickets predominantly stem from nutritional insufficiency 
[5]. Such nutritional insufficiency occurs when metabolites of vitamin D are 
deficient and less commonly can result from dietary deficiency of calcium or 
phosphorus.  
In 1921 Hess and UInger reported UV radiation was an effective treatment 
for rickets [2]. Today rickets remains rare in developed nations due to increased 
awareness and consumption of vitamin D fortified foods. However, low vitamin D 
status in adults is prevalent and has become a worldwide epidemic. Analogous to 
rickets in children, failure of osteoid to calcify in adults is termed osteomalacia. 
Vitamin D is not only important in optimal bone health, reducing the risk of 
osteomalacia and osteoporosis in adults [1], but low levels have also been 
implicated in many acute and chronic diseases such as cancer, diabetes, and 
cardiovascular diseases [6, 7]. More recently, maintaining sufficient vitamin D 
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status has been associated with improved musculoskeletal health [8] affecting 
muscle strength and size [7]. Age-related muscle mass decreases have been 
associated with increased risk for fractures and falls [9]. Concurrently, the high 
prevalence of vitamin D deficiency and insufficiency in the growing aged 
population leaves older adults susceptible to decreased muscle function and 
subsequently increased risk for falls. Therefore, it is imperative to effectively 
measure, assess, and understand the role vitamin D plays on skeletal muscle in 
older adults.  
1.1.1 Vitamin D Measurements 
In the human body, vitamin D exists in two main forms that differ in side 
chain structure. One of the forms is cholecalciferol (vitamin D3) which is mainly 
synthesized endogenously through skin exposure to UVB radiation. In addition, 
small amounts of vitamin D3 can also be obtained from dietary animal sources 
such as egg yolk and oily fish [2]. Ergocalciferol (vitamin D2) is the other form 
that is found in plants and yeast. Traditionally, vitamin D2 and D3 were thought to 
be equipotent; however, human studies have shown that raising 25-hydoxy 
vitamin D (25(OH)D) concentrations with vitamin D3 is more than 2-fold effective 
[2, 10]. Vitamin D2 is less effective in raising 25(OH)D concentrations because of 
the differences in binding affinities for vitamin D bind protein (VDBP) between 
vitamin D2 and D3. Vitamin D2 has a lower binding affinity to VDBP resulting in a 
shorter circulating half-life and increased circulating clearance rate than that of 
vitamin D3 [10]. It is vital to note that hepatic 25-hydoxylase has a higher affinity 
3 
for vitamin D3, converting it to 25(OH)D3 five times faster than the rate of 
conversion from vitamin D2 to 25(OH)D2.  
The vitamin D metabolite, 25(OH)D, is a diagnostic measure used to 
evaluate vitamin D status. Since the mid-1970s high performance liquid 
chromatography (HPLC) has been the gold standard for 25(OH)D assay as it 
provides the ability to quantify both forms (D2 and D3) [11]. Although 25(OH)D is 
the inactive form of vitamin D, it is the major circulating metabolite with a half-life 
of 2-3wks [12]. The highest concentration of 25(OH)D can be found in plasma 
and 25(OH)D is stored in the adipose and muscle tissues. Eighty-five percent of 
the inactive form 25(OH)D and the active form 1,25-dihydroxyvitamin D 
(1,25(OH)D) is bound to VDBP, 10-15% is bound to albumin, and 0.03% is free 
or unbound [13]. Although the majority of vitamin D is bound, the unbound 
portion of 1,25(OH)D, or active form, is able to exert biological activity, following 
the principle of the free hormone hypothesis [14]. The free hormone hypothesis 
states that unbound hormones are available to exert biological activity while 
hormones bound to proteins are relatively inactive. VDBP concentrations can be 
altered with pathological conditions and vary between individuals, this in turn can 
affect circulated 25(OH)D concentrations [14-17]. Researchers suggest that 
VDBP should be measured and assessed as VDBP concentrations could be a 
confounding variable when interpreting 25(OH)D concentrations [14]. 
The biologically active form of vitamin D is calcitriol, 1,25(OH)D, which is 
primarily produced in the proximal tubules of the nephron in the kidneys. 
Calcitriol is an inappropriate measure of vitamin D status due to its short half-life 
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of 4-6 hours and the circulated form that is 1,000 fold less than 25(OH)D [11]. 
Although 1,25(OH)D is an inappropriate measure of vitamin D status in healthy 
individuals, there are disease states in which it may be appropriate to measure 
1,25(OH)D. For example, patients with sarcoidosis, exhibit increased 1,25(OH)D 
concentrations as the immune cells produce calcitriol resulting in vitamin D 
toxicity and hypercalcemia. During chronic renal failure the disorder or the 
absence of 1-alpha-hydroxylase, enzyme located in the kidneys responsible for 
the conversion of 25(OH)D to 1,25(OH)D, results in reduced 1,25(OH)D 
concentrations [18]. Disease states can affect vitamin D measures; therefore, it is 
important to fully understand vitamin D metabolism and consider which vitamin D 
metabolites are necessary to assess.  
1.1.2 Vitamin D Metabolism  
 Vitamin D can be synthesized cutaneously through skin exposure to UVB 
rays or through dietary intake of natural and fortified foods or supplements. Pro-
vitamin D3 (7-dehydrocholesterol) is located in the epidermal skin layer and in 
response to heat-induced UVB radiation undergoes isomerization to form pre-
vitamin D3. Pre-vitamin D3 can 1) bind to the VDBP in the bloodstream and be 
transported to the liver where it undergoes hydroxylation or 2) be converted to 
tachysterol and lumisterol [2]. Excess exposure to UVB radiation results in the 
continuous production of the inactive compounds, tachysterol and lumisterol. 
Further, the inert compounds act as a reservoir and therefore can be converted 
back into pre-vitamin D3. This mechanism safeguards from sun-induced vitamin 
D toxicity. Conversely, vitamin D derived from natural foods, fortified foods and/or 
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supplements (vitamin D2 and D3) can be incorporated into chylomicrons, 
released into the lymphatic system, and then bound to VDBP in venous 
circulation. A small portion of the dietary vitamin D is extracted by adipose tissue 
and muscle; however, the remainder of dietary vitamin D and the most of the 
endogenously synthesized vitamin D is transported to the liver [2].  
In the liver, pre-vitamin D is hydroxylated by the enzyme 25-hydroxylase 
(also known as cytochrome p450) and converted to 25(OH)D (calcidiol). Next, 
25(OH)D is 1-hydroxylated by 25-hydroxyvitamin D 1-hydroxylase (1 alpha-
OHase), located primarily in the proximal tubules of the kidney, resulting in the 
active form 1,25(OH)D (calcitriol) [2, 19]. Although primarily the enzyme,1 alpha-
OHase, plays a role in the kidneys and converts calcidiol to the bioactive form 
calcitriol, the enzyme is also present in various tissue cells such as in 
keratinocytes, immune cells, myocytes, and osteoblasts which allows for vitamin 
D signaling at a local, tissue specific level [20].  
Serum parathyroid hormone (PTH) plays an important role in regulating 
the conversion of calcidiol to calcitriol. Calcium-sensing receptors located on 
chief cells in the parathyroid glands are stimulated during low serum calcium 
concentrations, to release PTH. Conversely, when calcium concentrations are 
high, reverse inhibition of parathyroid gland receptors occurs [21]. In addition, in 
the kidney, PTH can increase the activity of 1 alpha-OHase, which in turn 
increases the production of calcitriol. Calcitriol can act in the small intestine by 
binding to the retinoid-X receptor (RXR) to increase the transcription of epithelial 
calcium transporter proteins and calbindin. Calcium transporters and binding 
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proteins increase calcium absorption, raising serum calcium concentrations [2]. 
Further, PTH can bind to the PTH1 receptor located on osteoblasts. Upon 
prolonged PTH exposure, RANKL (located on the osteoblasts) binds to RANK 
(located on the osteoclasts) to stimulate bone resorption resulting in the release 
of calcium from the bone into the serum [22]. Conversely, intermittent exposure 
of PTH and higher calcitriol concentrations cause osteoblast proliferation, 
increases in bone mineralization, and decreased serum calcium concentrations.  
During high 25(OH)D concentrations, a negative feedback mechanism 
inhibits 25-hydroxylase decreasing further production of 25(OH)D in the liver [2]. 
Further, high 1,25(OH)D concentrations can inhibit 1 alpha-OHase reducing 
calcitriol synthesis in the kidney. Also, 1,25(OH)D can be degraded by 24-OHase 
to 1,24,25(OH)D (calcitroic aid) which undergoes biliary excretion. 
1.1.3 Vitamin D Sources 
Most notably, vitamin D can be obtained through UVB ray exposure. It is 
recommended that exposing the arms, legs, face, or back without sunscreen for 
5-30 minutes, at least 2 times a week between the hours of 10:00AM and 
3:00PM, would provide adequate vitamin D synthesis [23]. As a result of 5-10 
minutes of UVB exposure, 3,000IU of vitamin D3 can be cutaneously synthesized 
[24]. Individuals residing at latitudes above 35°N or below 35°S, during the 
months of November-March, synthesize minimal vitamin D through UVB ray 
exposure [25].  
The Recommended Dietary Allowance (RDA) for individuals between 1-70 
years of age is 600IU/d and for individuals older than 70 is 800IU/d [23, 26]. The 
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higher levels for older adults is recommended as decreases in intestinal 
absorption occur with aging [27]. Natural foods containing higher vitamin D levels 
include oily fish such as salmon (500-1000IU/3.5oz serving) and UVB-exposed 
mushrooms (~100IU/3.5oz serving) [24, 25]. To a lesser extent, foods such as 
beef liver and egg yolks also contain vitamin D. Fortified foods in the United 
States including milk, juice, and some cheeses and yogurts typically contain 
100IU/serving [23, 25, 28].  
Dietary vitamin D supplements can be consumed to increase and maintain 
25(OH)D concentrations. Current clinical guidelines for treatment of vitamin D 
deficiency is to supplement with vitamin D for 8wks (50,000IU/wk or 6,000IU/d), 
to achieve a concentration of 25(OH)D>30 nanograms/milliliter (ng/mL), followed 
by maintenance therapy of 1,500–2,000IU/d [27]. Heaney et al. [29] observed a 
20ng/mL and 30ng/mL increase in 25(OH)D in healthy overweight participants 
after administering 50,000IU/wk for 4 and 6wks, respectively. In addition, Ekwaru 
et al. [29] recommended 2-3 times greater vitamin D supplementation for obese 
individuals and 1.5 times greater for overweight individuals relative to normal 
weight individuals. These differences in vitamin D supplementation 
recommendations are a result of genetic and modifiable lifestyle factors that 
contribute to vitamin D status.  
1.1.4 Genetic Polymorphisms in VDBP that Modulate Vitamin D Status 
Genetic polymorphisms are the genetic variations that occur between 
individuals. VDBP variants are due to the polymorphisms in the VDBP gene 
guanine and cytosine (GC) and are defined as GC1F, GC1S, and GC2 [30]. 
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Genetic polymorphism in VDBP effect vitamin D status; therefore, previous 
research has investigated the role of physiologic factors on VDBP and 
subsequently on vitamin D status in pathologic conditions.  
Pathologic conditions such diabetes and cancer may alter VDBP and 
25(OH)D concentrations. In Type I diabetic patients with nephropathy, an 
increase in urinary loss of VDBP contributes to lower 25(OH)D concentrations 
[31]. Conversely, the role of VDBP in 25(OH)D concentrations and cancer risk is 
still emerging. VDBP has not been directly linked with increased risk of cancer, 
but as 25(OH)D is modulated by VDBP researchers suggest that examination of 
both 25(OH)D and VDBP are necessary to understand the association observed 
between vitamin D status and cancer risk [14, 32]. 
Physiological factors such as sex and race affect VDBP and 25(OH)D 
concentrations. Studies suggest that VDBP concentrations are greater in females 
than males potentially due to the effect of estrogen stimulating VDBP synthesis 
[14]. Although estrogen decreases with menopause, Kaeslin et al. [33] observed 
greater 25(OH)D concentrations in postmenopausal women compared with 
aged-matched males potential due to higher VDBP concentrations. Also studies 
have shown VDBP genetic polymorphisms are associated with race and could 
alter VDBP levels and binding affinity [14, 15]. The functional significance of 
these genetic polymorphisms are not yet completely understood, but VDBP can 
alter circulating 25(OH)D concentrations and should be considered as a potential 
confounding factor in the interpretation of 25(OH)D concentrations.  
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One study included a cohort of African American (n=1,181) and White 
(n=904) middle-aged adults [15]. The authors observed that African Americans 
had consistently lower 25(OH)D concentrations and lower VDBP compared with 
Whites; however, the estimated bioavailable 25(OH)D was similar. The 
bioavailable or free 25(OH)D is the circulating vitamin D that is not bound to 
VDBP. These data suggest that low 25(OH)D concentrations combined with low 
VDBP may not indicate vitamin D deficiency. Additionally, differences in race and 
protein variants have been observed. African Americans and Asians are more 
likely to carry the GC1F VDBP. GC1F has the highest affinity for 25(OH)D and is 
associated with low VDBP. Conversely, Whites are more likely to carry GC1S 
and GC2. GC2 has a lower affinity for 25(OH)D and is associated with higher 
VDBP concentrations [14]. Therefore, 25(OH)D concentrations are in part due to 
the genetic variation in VDBP, in which lower VDBP with greater binding affinity 
may be a genetic trait to protect African Americans from vitamin D deficiency 
[15].  
Lutsey et al. [34] provided another example of genetic variance influencing 
pathology between races. This study examined the association between 
25(OH)D, VDBP, and heart failure among Whites and African Americans (total 
n=12,215). The authors observed that lower 25(OH)D concentrations were 
independently associated with increased risk of developing heart failure but only 
in White individuals. However, in both White and African American individuals, 
who were genetically predisposed to higher VDBP, lower 25(OH)D was 
associated with greater risk of heart failure. With higher VDBP a greater portion 
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of 25(OH)D was bound and subsequently less vitamin D was bioavailable 
contributing to increased cardiovascular risk.  
A more recent study by Alzaman et al. [17] examined the effects of vitamin 
D supplementation (2,00IU/d or 4,000IU/d for 16wks) on bound and free 
25(OH)D between African American (n=57) and White (n=151) adults with pre- or 
well-controlled diabetes. Prior to supplementation, the authors observed that 
African Americans had lower total 25(OH)D but similar free 25(OH)D 
concentrations compared with Whites. In both races, an increase in free and 
bound 25(OH)D post-supplementation was observed. Further, lower VDBP 
concentrations were observed in African Americans when a monoclonal antibody 
immunoassay, a more widely used technique to measure VDBP was employed. 
However, this technique was scrutinized as falsely lowering VDBP values in 
African Americans due to the differentiation against a VDBP variant that is more 
common in African Americans. In light of this, the authors applied a polyclonal 
antibody technique, which resulted in no significant racial differences between 
VDBP concentrations. In addition, Nielson et al. [16] examined these techniques 
with a larger sample size (African American n=101; White n= 919). The authors 
confirmed that previous findings of racial differences in VDBP concentration may 
be attributed to the monoclonal assay bias as no racial differences exist when 
alternative methods were employed. Due to discrepancies between 
methodologies used, further investigation is warranted to assess if racial 
differences in VDBP concentrations truly exist.   
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Together these studies provide evidence to the importance of VDBP 
genetic polymorphisms and the effects of both pathological and physiological 
factors on VDBP. Disease states can alter the production of VDBP which 
modulated 25(OH)D concentrations. As low 25(OH)D have been associated with 
multiple diseases, the combination of examining both 25(OH)D and VDBP is 
important to the understanding of the effects of vitamin D on disease risk. 
Further, difference among opposite sexes exists, in which higher VDBP 
concentrations are typically observed in females compared with males. Racial 
differences in VDBP variants between African Americans (GC1F) and Whites 
(GC1S and GC2) exist. African Americans have lower VDBP but higher binding 
affinity to 25(OH)D compared with Whites and as a result the bioavailability of 
25(OH)D concentrations is similar between races. Due the racial variability in the 
VDBP gene, it is crucial that the techniques used to assess VDBP and free and 
bound 25(OH)D are taken into consideration.  
1.1.5 Factors that Modulate Vitamin D Status  
Considerable amount of the vitamin D requirements can be met through 
sensible UVB exposure, whereas very few foods naturally contain vitamin D and 
fortified foods typically only contain 100IU/serving [28]. Multiple factors play a 
role in the ability to synthesize vitamin D cutaneously. Factors such as time of 
day, season of the year, and latitude play an important role since the zenith angle 
of the sun changes with Earth’s rotation. The solar zenith angle becomes more 
oblique early or late in the day. Likewise, the angle is more oblique during the 
months of November-March and below 35°S or above 35°N [25]. At a more 
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oblique zenith angle the photons must travel longer distances through the ozone 
layer which make UVB rays more susceptible to absorption by the ozone, thus 
decreasing the amount of photons reaching the Earth’s surface [25]. In addition, 
the UVB rays that are not absorbed in the ozone layer can be absorbed by air 
pollution or clouds, reducing UVB energy by 50-60% [23]. 
The skin is comprised of the superficial thinner layer, epidermis, and the 
deeper layer, dermis. UVB rays (290-315nm) penetrate the epidermal layer, 
while UVA rays are longer in wavelength (320-400nm) and penetrate deeper into 
the dermis. Greatest 7-dehydrocholesterol concentrations are located in the 
epidermal layer of the skin and absorb UVB light at 290-320nm, thus UVB 
radiation is effective at converting 7-dehydrocholesterol to pre-vitamin D3.  
Other factors such as sunscreen and sunblock use and skin melanin 
content can reduce the skin’s ability to produce vitamin D [28]. When applied as 
directed, sunscreen with a sun protection factor as low as 8 can reduce 25(OH)D 
by approximately 20ng/mL [2]. Melanin is derived from tyrosine and is 
responsible for the pigmentation of human skin, pupils, and hair color. The 
natural selection hypothesis states that lighter skin color, at higher latitudes with 
lower UVB radiation, evolved to optimize and facilitate vitamin D production [35]. 
The Fitzpatrick scale can be used to estimate the response of various skin types 
to UVB exposure ranging from Type I (score 0-6, always burns and never tans) 
to Type VI (score 35-36, never burns or tans) [36]. Individuals with greater scores 
on the Fitzpatrick scale have more melanin, which can act as a natural 
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sunscreen. Individuals with skin Type I are 6-times more efficient at synthesizing 
vitamin D from UVB rays compared to individuals with a skin Type VI.  
With an increase in aging, atrophic skin changes occur and the thickness 
of the epidermal skin layer is reduced. 7-dehydrocholesterol is located in the 
epidermis and concentrations decrease with aging due to the thinning of the 
epidermal skin layer. In older adults, 7-dehydrocholesterol concentrations are 
two-fold lower compared with younger adults. With the reduction in pro-vitamin D 
concentrations, the ability to cutaneously form pre-vitamin D3 is decreased, 
subsequently leading to an overall decrease in 25(OH)D concentration [28]. Past 
studies have suggested that intestinal absorption of dietary vitamin D decreases 
with age; however, recent studies observed only minor structural changes to the 
small intestines that do not significantly contribute to altered vitamin D absorption 
[27].  
Due to the lipophilic nature of vitamin D3, adiposity also plays a role in the 
bioavailability of circulating 25(OH)D. The volumetric dilution and greater 
sequestration into the adipose tissue hypotheses have been attributed to the 
following observed associations [37-42]. In one meta-analysis, the prevalence of 
vitamin D deficiency was 24-35% greater in the overweight and obese individuals 
compared with the normal weight individuals [43]. Previously, our lab examined 
the role body composition and BMI play in 25(OH)D response after a 6-month 
vitamin D supplementation regimen (4,000IU/d) in athletes [40]. We observed a 
trend between lower fat mass and a lower decrease in 25(OH)D concentrations. 
Also a significant negative correlation between BMI and 25(OH)D change in the 
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supplement group was noted. Interestingly, BMI ranged from 18.5 to 26 
kilograms/meters2 (kg/m), with only 2 of 32 participants classified as overweight, 
suggesting that diminished 25(OH)D concentrations post-supplementation 
extended beyond overweight and obese individuals and included individuals in 
the normal BMI category. A recent systematic review [39] examined the effect of 
weight loss on 25(OH)D. The authors pooled randomized and non-randomized 
trials and observed a small, significant increase in 25(OH)D concentrations with 
weight-loss; however, a dose-response relationship was not detected. These 
studies suggest that increased adiposity lowers 25(OH)D concentrations, 
potentially increasing the risk of vitamin D deficiency or insufficiency in 
individuals with greater adiposity.  
1.1.6 Controversies in Vitamin D Recommendations 
To date, RDA requirements for vitamin D, UVB exposure, and 25(OH)D 
concentrations for optimal health remain controversial. Although the RDA 
requirements are set at 600-800IU/d for adults [23], many scientists have stated 
that this amount is inadequate and should be increased to at least 800-1,000IU/d 
[25]. The Endocrine Society suggests levels of 1,500-2,000IU/d may be 
necessary in order to raise 25(OH)D concentrations above 30ng/mL [27]. 
Furthermore, the National Institutes of Health Office of Dietary Supplements 
states that no vitamin D synthesis through sun exposure can occur without 
increased risk of skin cancer [23]. Conversely, due to the short time exposure to 
UVB radiation required to acquire adequate vitamin D levels, researchers 
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suggest that sensible sun exposure would lead to minimal risk in the 
development of skin cancer [28, 44].  
Similar to dietary intake and UVB exposure recommendations, a 
controversy exists about defining 25(OH)D cut-offs for deficiency, insufficiency, 
and sufficiency. Vitamin D deficiency has been set at 25(OH)D<20ng/mL, a cut-
off that is considered inadequate for bone health [24, 26, 27]. Vitamin D 
insufficiency is typically considered as 20-29ng/mL; however, some researchers 
suggest that the insufficiency range should be expanded to a concentration 
threshold of 32ng/mL as it has been established that this concentration increases 
intestinal calcium transport by 45-65% [6, 14, 24, 44-46]. Some researchers 
identifying sufficient vitamin D status starting at 30ng/ml [23], 32ng/mL [14], or 
more recently 40ng/mL [27, 28, 47, 48]. These concentrations are considered 
beneficial beyond maintaining optimal bone health and potentially promoting 
muscle health.  
Similarly, the upper limit for what is considered healthy is surrounded by 
controversy. The National Institutes of Health [23] identifies a 25(OH)D 
concentrations of >50ng/mL as being associated with potentially adverse effects. 
Conversely, the Endocrine Society practice guidelines suggest that 
concentrations up to 150ng/mL are safe and do not induce hypercalcemia [27]. 
The tolerable upper intake level set by the National Institutes of Health is 
4,000IU/d for individuals older than 9 years of age [18]. Excessive vitamin D 
intake can result in increased calcium levels, which may lead to an increased risk 
of kidney stones, tissue calcification, and damage to the heart and blood vessels. 
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However, individuals supplemented with 10,000IU/d for a period of 5-months 
reported no adverse events [23]. Further, Drincic et al. [41] suggested that 
normal weight individuals need 4,000IU/d and 5,000IU/d to sustain a 25(OH)D 
concentration of 32ng/mL and 40ng/mL, respectively.  
The recommendations for dietary intake, UVB exposure, and cut-off 
parameters for adequate vitamin D status vary between governmental 
recommendations and the recommendations of researchers. Due to these 
controversies, the prevalence of vitamin D deficiency reported in populations 
such as in older adults varies, as there is no standardized definition of vitamin D 
deficiency across all studies. Further, in studies examining the beneficial effects 
of vitamin D supplementation on health, varying vitamin D supplementation 
dosages are used leading to inconclusive data. The need for standardized 
definitions and cut-offs across the scientific community and governmental 
regulating bodies is both topical and essential for effectively addressing the issue 
of increased prevalence of vitamin D deficiency. For the purpose of this 
dissertation vitamin D status will be defined as deficiency set at 
25(OH)D<20ng/mL, insufficiency set at 20-30ng/mL, and sufficiency 
25(OH)D≥30ng/mL. 
1.1.7 Vitamin D Status in Older Adults 
 Vitamin D deficiency and insufficiency is a worldwide epidemic and there 
is an especially high prevalence of low vitamin D status in older adults [24]. In 
part, this high prevalence can be attributed to cutaneous decreases in vitamin D 
synthesis due to decreased concentration of 7-dehydrocholesterol in the 
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epidermal skin layer. Likewise, disease states and physiological changes can 
alter vitamin D pharmacokinetics (the effect the body has on vitamin D) and 
pharmacodynamics (the effect vitamin D has on the body) [46]. One physiological 
example is the decrease of calcitriol production due to decreasing renal function 
observed with aging. Studies suggest that 40 to 100% of older community-
dwelling adults are vitamin D deficient [24, 49, 50]. In part, this wide range of 
vitamin D deficiency is due to diverse cut-off parameters set for vitamin D 
deficiency and heterogeneity of both physiological and lifestyle factors in the 
older population.  
It is justified to distinguish between community-dwelling and 
institutionalized older adults. Typically, community-dwelling adults are younger, 
more independent, and have a lower prevalence of vitamin D deficiency primarily 
due to increased time spent outdoors [49, 51]. A decline in bone and muscle 
mass occur with aging, which can result in increased nursing home admission 
and hospitalizations [50]. With institutionalization, a decrease in mobility and time 
spent outdoors further contributes to lower vitamin D status. The concern of low 
vitamin D status in older adults has been aimed at maintaining adequate vitamin 
D and calcium levels to reduce the risk of falls and bone fractures [52]. However, 
bone and muscle tissues are functionally linked. Vitamin D can exert its influence 
beyond the bone by acting on skeletal muscle, potentially preserving muscle 
strength and function during aging, leading to an overall decrease in risk of falls 
and fractures [49]. 
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1.1.8 Muscle Health and Aging Physiology  
Sarcopenia, defined as the age-related loss of muscle mass, is greatest 
after 50 years of age, with rates of muscle mass decline at 12-15% per decade. 
Muscle loss effects men and women differently, with men experiencing greater 
loss than women potential due to decreases in testosterone with aging [53]. The 
progressive muscle wasting with aging decreases physical function and 
increases the risk of falls leading to a loss of independence and an increase in 
morbidity and mortality [9, 49]. As the population of 65 year olds is expected to 
double in the next 30 years, interest in combating sarcopenia and improving 
quality of life are rising [54].  
Loss of muscle mass leading to decreased muscle strength and function is 
a multifaceted issue. Histologically, decreases in the amount and size of 
mitochondria and a decline in the number of Type I (slow twitch) and Type II (fast 
twitch) muscle fibers is seen with aging. Both increased inflammation and 
lipotoxicity along with decreased neuronal stimulation, muscle protein synthesis, 
and capillary blood flow occur with aging further contributing to sarcopenia [9]. 
Studies have shown that increased ectopic fat depots in muscle are associated 
with reduced strength and performance [55, 56]. These factors combined limit the 
ability of the muscle to generate power with age and compromise muscle 
function, which lead to a decrease in quality of life. It is evident that modifiable 
lifestyle factors such as aerobic and resistance training and nutrition can play a 
significant role in preserving or limiting the progression of muscle mass loss [57].  
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1.1.9 The Role of Vitamin D in Muscle Physiology during Aging  
Generally, low vitamin D status has been associated with functional 
limitations and poor physical performance in older adults [38, 49, 50]. However, 
randomized controlled trials and observational studies have yielded mixed 
results. A recent systematic review and meta-analysis concluded that vitamin D 
supplementation had limited influence on muscle strength and mobility 
preservation in older adults [49]. However, studies included in the analysis widely 
varied in type of vitamin D supplementation (D2 or D3), dosage of vitamin D, and 
the combination of vitamin D supplementation with calcium. In addition, functional 
performance and strength tests varied between assessed interventions. 
Therefore, the authors suggested that the small sample size among individual 
trials and heterogeneity of studies preclude the ability to form a fixed conclusion 
[49]. A 3-year longitudinal study reported that deficient vitamin D status 
(25(OH)D<20ng/mL) was associated with a 2-fold increased risk of muscle mass 
loss compared with sufficient vitamin D status (25(OH)D>30ng/mL) in older 
adults [58]. In a sample of 20 older adults between the ages of 65-85, our lab 
observed a significant positive relationship between higher 25(OH)D 
concentrations and faster Four-Square-Step Test times (FSST); however we did 
not see a relationship between vitamin D status and other physical performance 
(gait speed, timed up and go, and 5-times sit-to-stand) or strength measures [59]. 
An observational study that included over 2,000 older adults suggested that 
vitamin D deficiency was associated with weaker handgrip strength and lower 
performance measures (gait speed, 6-minute walk, and 5-times sit-to-stand) 
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when compared with individuals with 25(OH)D>40ng/mL [60]. Higher 
concentrations of 25(OH)D were also associated with better lower extremity 
function (8-foot walk and sit-to-stand test) in both inactive and active adults 60 
years of age or older [61]. Lower-extremity function improved from 3.9 to 5.6% 
from the lowest to the highest 25(OH)D quintile. Further this study suggests that 
it may be advantageous to reach and maintain 25(OH)D concentrations between 
36.5-40ng/mL as these levels were associated with better lower-extremity 
function. Other research also suggests that 25(OH)D concentrations greater than 
40ng/mL may be beneficial for muscle health [27, 28, 47]. Shuler et al. [47] 
reviewed the role vitamin D plays in athletes, the authors’ suggest that decreased 
risk of stress fractures occurs at 40-50ng/ml and potential athletic performance 
enhancement occurs at 50-60ng/mL. In addition, due to variability in assays used 
to assess 25(OH)D, Hossein-nezhad et al. [28] suggests that maintenance of 
25(OH)D between 40-60ng/mL is ideal. Similarly, the Endocrine Society suggests 
that maintenance of 40ng/mL ensures that the individuals’ true 25(OH)D 
concentrations is greater than 30ng/mL [27]. The Endocrine Society also notes 
that PTH levels begin to plateau in adults with a 25(OH)D concentration between 
30-40ng/mL, this normalization of PTH indirectly implies that this 25(OH)D 
concentration can be used to define insufficiency (25(OH)D<30ng/mL). Together 
these studies suggest that 25(OH)D≥30ng/mL should be considered as sufficient, 
but a 25(OH)D>40ng/mL ensures that sufficient status is met and may be 
beneficial for muscle health.  
21 
The effects of maintaining sufficient vitamin D status on physical function 
in older adults is under investigation. A 5-year prospective study observed that 
higher vitamin D levels with adequate physical activity may prevent functional 
decline [38]. This study followed 615 community-dwelling adults over the age of 
50 and observed that higher vitamin D and physical activity levels were 
associated with decreased gains in body fat and decreased decline of muscle 
mass. Likewise, during exercise, higher vitamin D levels were associated with 
increased fat oxidation, further contributing to overall improved muscle health 
[62, 63]. Sinha et al. [63] examined the effects of vitamin D supplementation 
(20,000IU of vitamin D3 every other day for 10-12wks) on skeletal mitochondrial 
oxidative function in severely deficient adults (n=12, 25(OH)D<6ng/mL, age: 18-
50) that presented to a primary care facility with fatigue or muscle cramps. The 
authors’ observed an improvement in mitochondrial oxidative function as serum 
25(OH)D was negatively associated with phosphocreatine recovery half-time (T1/2 
PCR). Magnetic resonance spectroscopy was used to quantify the T1/2 PCR, the 
time for PCR to decrease below 50%. PCR is typically used as an index to 
measure mitochondrial oxidative capacity. PC is readily and rapidly broken down 
by creatine kinase into creatine and phosphate. The phosphate is then donated 
to adenosine diphosphate (ADP) to form adenosine triphosphate (ATP) which is 
used to fuel the cell for short intense activity (<10s). The resynthesis of PC post-
exercise is inversely proportional to the rate of oxygen consumption, suggesting 
that PC recovery could be used as an index of oxidative ATP production and a 
measure of mitochondrial function [64]. Further higher 25(OH)D concentrations 
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were positively associated with improvements in fatigue and myopathy 
symptoms. These studies suggest that there may be synergistic interaction in 
which vitamin D and exercise combined are multiplicative and not simply additive 
[53] and provide a protective effect for muscle decline. In combination, these 
findings may suggest that vitamin D supplementation, which increases and 
maintains adequate 25(OH)D concentrations, may result in muscle function 
improvements for those who have a baseline vitamin D deficiency. 
Over the past several years researchers have been investigating the direct 
and indirect effects vitamin D has on muscle tissue. Vitamin D can act on the 
skeletal muscle through genomic and non-genomic pathways involved in cellular 
metabolism and function. The genomic pathway is slow-acting; whereas the non-
genomic pathway is fast-acting (seconds to minutes). Vitamin D receptors (VDR) 
and CYP27B1 (gene which codes for the protein 1 alpha-OHase) are both 
expressed in adult muscle cells allowing for circulating and locally converted 
calcitriol to act on the muscle [65, 66]. VDR is a ligand-dependent transcription 
factor. Once VDR is bound by calcitriol it can translocate to the nucleus and play 
a role in the genomic pathway. In the nucleus, VDR forms a heterodimer with the 
RXR and binds to the vitamin D response elements in skeletal muscle’s DNA, 
thereby activating gene transcription and expression [66-68]. It is thought that 
binding of calcitriol to non-genomic VDR promotes the phosphorylation of 
intracellular proteins and formation of second messengers, which upregulate 
intracellular calcium and increase pathways involved in muscle protein synthesis 
[66-68]. Vitamin D regulates muscle contractions through controlling calcium 
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handling within the muscle cell [2]. During a muscle contraction nerve stimulation 
cause a depolarization of the sarcolemma, which leads to calcium release from 
the sarcoplasmic reticulum. Calcitriol can act on calcium binding proteins such as 
calmodulin, located on the sarcolemma and sarcoplasmic reticulum, to regulate 
calcium flux [66].  
Unfortunately, these genomic and non-genomic pathways may be less 
efficient with aging as skeletal muscle VDR expression was negatively 
associated with age in muscle tissue of female orthopedic patients [69]. These 
findings were independent of biopsy location or 25(OH)D concentrations. There 
was no relationship reported between VDR expression and vitamin D status, 
which may be due to the small sample size (n=20) and primarily low 25(OH)D 
concentrations (<20ng/ml). This cross-sectional trial was not able to address 
whether VDR expression could be increased by vitamin D supplementation in 
vitamin D deficient individuals. As vitamin D and VDR play an important role in 
muscle strength and performance observational and randomized controlled trials 
have been completed to understand the mechanistic role of vitamin D and VDR 
in muscle health [68].   
One study observed that treatment with calcitriol in human myoblasts 
increased VDR gene expression in a dose-dependent manner [70]. Vitamin D 
supplementation increased VDR concentration and cross-sectional muscle fiber 
size in human cells [65, 71]. In C2C12 mice myoblasts, similar results were seen 
as treatment with calcitriol increased protein synthesis [66]. Furthermore, as part 
of a randomized double-blind placebo-controlled trial, vitamin D supplementation 
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over 4-months had a persistent 20% increase in VDR expression and muscle 
fiber size in women 65 years of age or older [65, 66]. 
1.2 Musculoskeletal Lipid Droplets Characteristics 
Musculoskeletal lipid droplets can be classified as intramyocellular (IMCL) 
or extramyocellular (EMCL) lipids. IMCL is fat that is stored within the muscle 
cell, typically in close proximity to the mitochondria [72, 73]. Conversely, 
extramyocellular lipid is adipose tissue accumulation outside of the muscle cell.  
This adipose tissue accumulation infiltrates the interstitial layers of the muscle 
[74].   
1.2.1 Intramyocellular Lipid Characteristics 
Skeletal muscle lipid depots serve as a dynamic energy substrate. There 
exists a high degree of IMCL heterogeneity including size, cellular location, and 
type of proteins located on the lipid droplet phospholipid monolayer [73]. IMCL 
can range between 0.3um and 1.5um in diameter, with larger sized and greater 
amount of IMCL droplets in Type I (oxidative slow twitch) compared with Type II 
(fast twitch) muscle fibers [75]. IMCL is located in-between a series of 
sarcomeres, known as myofibrils, and is typically located adjacent to the 
mitochondria [72]. Although lipid droplet motion during muscle contraction 
remains somewhat uncharacterized, researchers assume that due to the 
restrictions within the cell very limited movement occurs [73].  
Primarily, IMCL is comprised of triacylglycerol (TAG) and diacylglycerol 
(DAG) and multiple enzymes play a role in lipid depot formation. 
Monoacylglycerol (MAG) can be acylated to form DAG with subsequent acylation 
25 
to form TAG. Both monoacylglycerol acyltransferase (MGAT) and DAG-O- 
acyltransferase (DGAT) play a role in the MAG-DAG-TAG pathway. Furthermore, 
two isoforms of DGAT enzymes are located within the muscle (DGAT1 and 
DGAT2). DGAT1 and DGAT2 are located in the endoplasmic reticulum, but 
DGAT2 is also located on the mitochondrial membrane and may also be located 
on the lipid droplet monolayer. DGAT2 is thought to be involved in the formation 
of TAG [73]. These lipid droplets are synthesized in the endoplasmic reticulum, 
however the precise mechanism by which the lipid droplets are formed is still 
under investigation.  
Coat proteins are embedded throughout the phospholipid monolayer [73, 
76]. Five proteins comprise the major protein family, perilipin (PLIN 1-5) [73, 76]. 
PLIN 2-5 are localized in the skeletal muscle [73, 76]. Specifically, PLIN2 aids in 
lipid storage [73], PLIN3 plays a role in fat oxidation [73], and PLIN4 assists with 
packaging of newly synthesized lipids [73, 76]. PLIN5 plays a role in the 
interaction between the mitochondria and the lipid monolayer [73]. It has been 
observed that endurance training increases PLIN5 expression [73, 76]. In 
skeletal muscle, PLIN5 increases IMCL oxidative gene expression and thereby 
may regulate substrate oxidation during exercise [73].  
1.2.2 Factors Playing a Role in IMCL Turnover 
Over the past decade, researchers have shown that IMCL depots are 
extremely dynamic [72]. Increased IMCL content has been associated with aging, 
insulin resistance, Type II diabetes, and obesity [72, 77]. Conversely, increased 
IMCL content has also been observed in athletes with high endurance leading to 
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the term “athletes paradox” [77]. In addition to an athletic population, obese 
individuals after an aerobic exercise intervention experienced higher IMCL with 
improved insulin sensitivity and greater oxidative capacity [74, 77, 78]. Due to the 
paradoxical association of IMCL with insulin sensitivity and resistance, IMCL has 
garnered prodigious interest from the scientific community.  
Many factors play a role in IMCL accumulation, including age, adiposity, 
diet, and exercise. Although aging has been associated with higher IMCL and 
increased insulin resistance, this relationship is multifactorial. For example, de la 
Maza et al. [79] compared healthy younger and older men and observed that a 
greater IMCL content was associated with increased abdominal fat and insulin 
resistance, independent of age. Choi et al. [80] compared normal weight and 
obese older adults and observed that the obese group had a greater percentage 
of Type I muscle fibers and a 2-fold greater number and total area of the lipid 
droplets. Increased IMCL was associated with lower force, power, and slower 
contractions in the muscle fibers. Conversely, acute (7 consecutive days) [74] 
and chronic (16wk) [77] aerobic exercise interventions in older adults were 
shown to improve insulin sensitivity, increase IMCL content [74, 77], and improve 
oxidative capacity [77]. Our lab previously observed a positive relationship 
between vitamin D status and IMCL in older adults, independent of physical 
activity and BMI [59]. Also in C2C12 myotubes, calcitriol had a 1.5-2.0 fold 
increase in expression of IMCL packaging proteins PLIN2 and PLIN3 [81]. In 
combination, these data suggest that vitamin D and exercise may play a positive 
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role in IMCL accrual, which can be oxidized during times of increased muscle 
energy expenditure.  
1.2.3 Extramyocellular Lipid Characteristic and Function 
EMCL are visible adipocytes located within the muscle tissue and between 
both muscle groups and muscle fibers [74, 82]. The physiological function of 
EMCL still remains largely unreported and unknown [74, 83]. However, greater 
EMCL accumulation has been observed with aging, greater adiposity, impaired 
insulin sensitivity, and reduced physical function [58, 74, 84].  
Hogrel et al. [85] observed that individuals’ 70-80 years of age had greater 
EMCL compared with younger healthy individuals. Furthermore, it was observed 
that EMCL was greater in older overweight men compared with older normal 
weight women. Likewise, with greater BMI levels greater EMCL levels were also 
observed [84]. Velan et al. [84] observed that overweight young adult males had 
greater EMCL compared with normal weight males. Correspondingly, de la Maza 
et al. [79] observed similar results in which greater central obesity was 
associated with greater EMCL and insulin resistance. It is essential to note that 
Haus et al. [74] observed a decrease in EMCL and insulin resistance after 7 
consecutive days of aerobic training in obese, insulin resistant men.  
Previous work has observed that lower 25(OH)D concentrations were 
associated with greater EMCL in both the young and elderly. Tagliafico et al. [55] 
observed that in the elderly vitamin D deficiency was associated with reduced 
physical performance (balance and gait) and increased EMCL of the thigh. 
Similarly, in young healthy women, vitamin D insufficiency was associated with 
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increased EMCL [86]. Previously our lab found no relationship between EMCL, 
25(OH)D, BMI or muscle strength and performance measures [59]. These results 
may differ from aforementioned findings due differences in subject 
characteristics, sample size, vitamin D status, and techniques used to quantify 
EMCL.  
1.3 Diet and Muscle Lipid 
The interest in how dietary intake plays a role in preserving muscle health 
is essential in maintaining muscle strength and function, which decreases with 
aging [57]. As muscle lipid depots can affect muscle function, the role of diet on 
IMCL and EMCL changes has garnered much interest. Initially it was thought that 
through increased caloric intake, there was an increase in fatty acid uptake, 
adding to the lipid overflow and leading to fat storage in the muscle [30]. With 
concurrent low mitochondrial lipid oxidation and lipid turnover, muscle lipid was 
implicated in increased insulin resistance [77]. However, the accretion of muscle 
lipid (IMCL) congruent with greater mitochondrial oxidation and lipid turnover can 
lead to improved insulin sensitivity. Recent data suggests that multiple lifestyle 
factors can play a role in muscle lipid metabolism.  
Dietary interventions may play a key role in reducing lipid overflow and 
fatty acid processing in the skeletal muscle. Previous data suggests that there 
are inter-individual gene expression changes in response to a high fat diet (HFD). 
Studies have observed increased fat oxidation in lean subjects but not in obese 
subjects. In order to further explore this relationship Kakehi et al., [87] examined 
the effect of a HFD in healthy non-obese men. The 3-day HFD consisted of 60% 
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fat (~45% saturated fatty acid (SFA), ~30% monounsaturated fatty acid (MUFA), 
~25% polyunsaturated fatty acid (PUFA)), 20% carbohydrates, and 20% protein. 
The authors examined high responders, those with large increases in IMCL, 
versus, low responders, those with small increased in IMCL. The authors 
observed that the high responders had upregulated gene expression related to 
fatty acid oxidation. A short-term HFD may result in free fatty acid influx, which 
exceeds the expenditure in the skeletal muscle leading to IMCL accumulation 
and increased insulin resistance. The upregulated fatty acid oxidation gene 
expression may suggest a compensatory mechanism to decrease lipid 
accumulation. 
Many studies suggest that the type of fat SFA, PUFA, or MUFA is an 
important factor in lipid metabolism [88, 89]. In a single-blinded randomized 
crossover trial, older insulin resistant men consumed either a high SFA, MUFA, 
or PUFA diet [89]. The authors observed that compared with a high SFA diet, a 
high PUFA diet was associated with reduced muscle uptake of fatty acids and an 
increase in IMCL turnover. Furthermore, a higher MUFA and PUFA diet may 
result in lower uptake of lipids into the skeletal muscle, as PUFA and MUFA rich 
chylomicrons may be removed from the circulation via hepatic lipase instead of 
lipoprotein lipase.  
St-Onge et al. [90] examined the effects of 25d crossover controlled 
feeding trial. Participants (19-65YO) consumed a low fat diet (14.2% from MUFA, 
8.5% from SFA, and 5.2% from PUFA), a HFD (15.9% from MUFA, 11.4% from 
SFA, and 5.8% from PUFA), and a high PUFA diet (15.3% from MUFA, 8.5% 
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from SFA, and 9.7% from PUFA). The authors hypothesized that a higher PUFA 
diet would result in lower IMCL accumulation compared with a HFD, as 
unsaturated fatty acids are more readily oxidized compared with SFA. However, 
they observed a decrease in IMCL after a low fat diet and an increase in IMCL in 
both HFD interventions. The authors concluded that IMCL content is not 
modulated by the dietary fat type but the total fat intake. Further, other 
researchers have noted that the amount of IMCL is not as important as the 
content and turnover of the IMCL [88, 89]. 
Animal models have suggested that the specific types of fatty acids exert 
different influences on IMCL. Although, both unsaturated fatty acids and SFA 
may lead to IMCL accretion, unsaturated fatty acids are preferentially oxidized 
over SFA [88]. Overwhelmingly, cell and animal models have suggested that 
SFA and trans-fats reduce insulin sensitivity, while PUFA improve insulin 
sensitivity [88, 91]. Specifically, in cell studies, SFA such as palmitate, the most 
prevalent free fatty acid in the plasma, alongside with stearate and arachidate 
can be stored as IMCL and induce DAG and ceramide synthesis, inhibiting AKT 
which results in downregulation of GLUT4. Together these actions lead to a 
reduction in insulin sensitivity and overall decreases in glucose uptake. 
Conversely, rodents fed a HFD enriched with n-3 PUFA, had a protective effect 
against insulin resistance development. Specifically, eicosapentaenoic acid and 
docosahexaenoic acid may increase lipid turnover by upregulating genes 
involved in lipid oxidation [88]. Mice fed a HFD enriched with n-3 PUFAs for 
10wks had a decrease in ceramide and long chain Acyl-CoAs implicated in 
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increased insulin resistance [92]. The authors suggested that an n-3 PUFA diet 
effects muscle lipid content by decreasing the bioactive lipid mediators, which 
negatively influence insulin signaling. Although the authors did not report any 
difference in mitochondrial oxidative capacity, they suggested that mitochondrial 
membrane fluidity increases with an n-3 PUFA, while a high SFA diet can cause 
rigidity in the membrane. Therefore, it is feasible that n-3 PUFAs would promote 
an overall greater mitochondrial oxidation leading to greater lipid turnover.  
To a lesser extent studies have examined the relationship between diet 
and EMCL. Higher EMCL content was seen with obesity and has been 
associated with insulin resistance. It remains unclear if EMCL is a marker of 
insulin resistance or plays a role in contributing to insulin resistance. Haus et al. 
[74], completed a combined intervention of a low-glycemic index diet and 
exercise. The authors’ observed a decrease in EMCL, increase in IMCL, and 
improved insulin sensitivity, but attributed these findings to the exercise regimen 
and not the dietary changes. Studies have shown that a decrease in total caloric 
intake and weight loss can lead to significant decreases in EMCL. However, 
weight loss in older adults who may already be frail or have lower BMI may not 
be a desirable option and instead physical activity should be considered [30].  
1.4 Physical Activity and Muscle Lipid 
Physical activity and exercise are related but differ in their definition. 
Physical activity is defined as voluntary or involuntary body movement produced 
by the muscle that results in energy expenditure, whereas exercise is defined as 
a subset of physical activity that is structured, planned, and repetitive and used 
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for the purpose to gain or maintain strength and aerobic capacity [93]. Exercise 
has been implicated in both IMCL and EMCL. Multiple exercise interventions in 
both young and older individuals have been conducted over the years to further 
understand the effects of exercise on muscle lipid depots. One study recruited 
both obese men and women, 60-75 years of age for a 16wk exercise intervention 
[77]. The participants completed a 4-5d/wk, 45-minute session at a moderate 
intensity (75% of heart rate maximum). Post-exercise, 21% increase in IMCL and 
a decrease in both DAG and ceramides was observed. In addition, oxidative 
capacity and capillary density improved. An 8wk randomized controlled trial 
examined the effects on IMCL and skeletal muscle oxidative phosphorylation 
[94]. Obese adolescence completed 20-minutes of stationary bicycling at 60-80% 
heart rate reserved (difference between resting heart rate and maximum heart 
rate) followed by 25-minutes of combined stretching and resistance training. The 
authors observed an improvement in overall fitness and power, and consistent 
with increased resting energy expenditure and lower respiratory quotient, an 
increase in IMCL. These data suggest that there is a greater reliance on lipid 
oxidation after an exercise intervention. Haus et al. [74] examined the effects of a 
shorter, 7 consecutive day, exercise regimen (60 minutes/d, ~80-85% of heart 
rate maximum) on insulin resistance, obese men. The authors observed a 
decrease in EMCL and an increase in IMCL with improved insulin sensitivity 
suggesting a potential change in lipid oxidation and mobilization to support 
muscle demands. 
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Unlike the aforementioned studies, Rouffet et al. [95] examined the 
immediate muscle lipid changes in healthy, normal-weight to overweight males 
with a combined short-term dietary intervention and exercise test. In this sample, 
the authors observed that overall higher IMCL stores were associated with 
greater VO2 max. A significant decrease in IMCL was observed after a 2-hour 
exercise (treadmill walking at 50% VO2 max) leading to conclude that IMCL is 
consumed and used during aerobic exercise. IMCL levels also increased after a 
3d fat depletion-repletion diet (depletion equated to an intake of 26% fat, 58% 
carbohydrate, and 16% protein for 2.5d followed by a repletion phase of 58% fat, 
24% carbohydrate, and 18% protein intake) compared with a high fat diet (58% 
fat, 24% carbohydrate, and 18% protein) alone. These studies provide evidence 
for the dynamic storage and mobilization of IMCL with short and long-term 
exercise interventions.   
1.5 Scope of Dissertation 
 Aging is associated with changes in musculoskeletal health. Both muscle 
strength and performance are reduced with age and muscle lipid metabolism is 
altered. Vitamin D status, diet, and exercise all play a role in muscle lipid 
metabolism and contribute to overall health and quality of life. Low vitamin D 
status has been associated with increased EMCL and previously our lab 
observed a positive linear relationship between 25(OH)D concentrations and 
IMCL. However, there is a need to further examine how 25(OH)D and muscle 
lipid depots related with physical function in a healthy older cohort. Furthermore, 
studies have examined the effect of short-term dietary interventions on muscle 
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lipid depot changes, but to date no research has been presented examining the 
relationship of daily dietary habits and muscle lipid depots in older adults. 
Preceding studies have examined the effect of structured exercise interventions 
on muscle lipid; however, we will focus on how physical activity relates to muscle 
lipid depots. 
 Specific Aim 1. To examine the relationship between 25(OH)D 
concentrations and muscle lipid depots (IMCL and EMCL) in older adults. 
Multiple factors contribute to this relationship including age, adiposity, and 
physical activity. This chapter will discuss and compare the relationship between 
vitamin D status and muscle lipid depots among older adults with different levels 
of physical activity and adiposity.  
 Specific Aim 2. To elucidate the relationship between dietary intake and 
physical activity on local muscle tissue hemodynamics and muscle lipid in older 
adults. This chapter will discuss how dietary intake, specifically fat intake, relates 
with muscle lipid depots. Further, structured exercise is known to improved global 
and local tissue hemodynamics and this chapter will focus on the potential 
relationship between physical activity levels and local muscle tissue 
hemodynamics. 
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Chapter 2: Methods and Materials 
2.1 Novel Techniques 
 The skeletal muscle is involved in both mechanical and metabolic function 
[96]. From a mechanical perspective, skeletal muscle is important for body 
movement and posture control, which contribute to overall health and functional 
independence. Metabolically, skeletal muscle plays an important role in glucose 
homeostasis, fuel oxidation, and strongly influences basal metabolic rate [96]. 
Due to its important mechanical and metabolic function, various techniques have 
been developed to quantify and assess skeletal muscle. Throughout history, 
skeletal muscle has been difficult to quantify in vivo [97]. Traditionally skeletal 
muscle was quantified through indirect measures such as urinary creatinine 
excretion [98]. Recently, more sophisticated techniques have been used such as 
Magnetic Resonance Imaging (MRI), computed tomography (CT), and Dual-
energy X-ray absorptiometry (DXA) (Table 2.1).  
These advanced techniques are especially important and are utilized to 
observe and analyze muscle decline with aging. MRI provides a participant 
friendly and non-invasive method to obtain high resolution MR images. Our lab 
used MRI and MR spectroscopy (MRS) to examined both EMCL and IMCL in 
adults 60 year of age or older. Further, our lab used non-invasive instrument that 
combines Near-Infrared Spectroscopy and Diffuse Correlation Spectroscopy 
(NIRS/DCS) to monitor blood flow and oxygen consumption during a dynamic 
foot plantar flexion exercise protocol. The combined techniques, MRI and 
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NIRS/DCS, allow us to examine muscle lipid and hemodynamics, and use these 
variables as an index to monitor local muscle tissue metabolism.  
2.1.1 MRI and Muscle Lipid Depots 
MRI is a non-invasive imaging instrument that can produce detailed 3-
dimensional images of the body including soft tissues, bones, and organs [99]. In 
order to produce these images MR uses the magnetic properties of atoms. The 
most abundant atom in the human body is hydrogen, which is commonly found in 
water and fat. Atoms have 3 types of motion, which include electrons spinning on 
their own axis, electrons orbiting the nucleus, and the nucleus spinning itself 
about its own axis. In the absence of an applied magnetic field hydrogen nuclei 
are randomly orientated, but when a strong static external magnetic field is 
applied most hydrogens align with the magnetic field. The MR produces a strong 
magnetic field which forces low-energy nuclei to align their axis of rotation 
parallel to the static external magnetic field (B0), whereas high-energy nuclei 
align anti-parallel to B0. Only a couple of hydrogens out of every million are not 
aligned with the magnetic field; however due to the high number of hydrogen 
atoms in the body these non-aligned hydrogens allow for a detailed image. With 
a greater B0 (or higher Tesla) more hydrogens are aligned with the magnetic 
field, which results in an improved signal, image resolution, and overall image 
quality. It is important to note that each hydrogen nucleus spins on its own axis 
and the B0 produces a secondary spin or wobble, termed precession, to the 
hydrogen. Further, each nuclei has a gyromagnetic ratio, which is defined as the 
ratio of the magnetic momentum of an atom compared to its angular momentum 
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(the momentum an odd mass nuclei has in which the number of neutrons is 
slightly more or less than that of protons resulting in a net spin or angular 
momentum). These concepts are important as each nuclei has its own 
gyromagnetic ratio and when exposed to the same field strength will precess at 
different frequencies. For example hydrogen will precess at a different frequency 
than carbon, which allows researchers to focus imaging on hydrogen and ignore 
other atoms in the body.  
In order to produce an MR image a short burst of energy in the form of 
electromagnetic radiation known as radio frequency (RF) pulse must be added 
towards the body part being imaged. When the RF pulse is applied, it allows for 
excitation to occur by forcing the unmatched hydrogens to spin at a particular 
frequency and direction, this is termed resonance. Both echo time (TE) and 
repetition time (TR) are the basic RF pulse sequence parameters measured in 
milliseconds (ms). TE is defined as the time from the application of the RF pulse 
to the peak of the signal in the coil and TR is the time between each excitation 
pulse. During the RF pulse, 3 gradient magnets, which are magnets inside the 
MR scanner with lower magnetic field strength, are turned on and off to alter the 
main magnetic field to create slices. Slices are area-specific images in which the 
body part can be observed in any of the 3 axis: sagittal (X), coronal (Y), and 
transverse (Z). When the RF pulse is off, hydrogens realign with the magnetic 
field and the energy absorbed from the RF pulse is released and the signal is 
received by the coil. Through a series of mathematical formulas, termed the 
Fourier transform, the data is transformed into an image. 
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The images, either T1- or T2-weighted, have a contrast gradient which 
emphasizes contrast characteristics of anatomical structures and allows 
researchers and physicians to examine different tissues. T1-weighted images are 
characterized by bright fat and fatty bone marrow and dark water with short TE 
and TR, whereas T2-weighted images are characterized by bright water and dark 
fat using longer TE and TR. Due to the better signal-to-noise ratio during 
scanning, T1-weighted images result in better anatomical delineation and are 
typically used. T1-weighted images depend on the differences between fat and 
water. If the TR is too long, both fat and water would return to B0 and the contrast 
between the two would be reduced, resulting in an image with poor differentiation 
of tissue. Thus, short-time TR parameters are set, which do not allow either 
water or fat to fully return to B0 after a RF pulse is applied, resulting in a high-
contrast resolution image. In addition, due to the different resonance frequency 
between fat and water a chemical shift artifact occurs which produces white or 
dark bands on either side of the anatomical object. In order to reduce this artifact 
we use the same parameters to produce a fat saturated image. In this image we 
suppress the signal from fat. Saturation of the fat signal allows for better contrast-
to-noise ratio and it is used to calibrate the non-fat suppressed image. Therefore, 
the two MR images, non-fat saturated and fat saturated, are used to provide a 
conventional MRI image of anatomical features.  
Conventional MR imaging is used to assess structural images; however 
new functional imaging techniques, such as MRS, are used to assess metabolic 
changes in the body. MRS produces a spectrum that plots signal intensity versus 
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frequency rather than an anatomical image. The signals at specific chemical 
shifts (parts per million (ppm)) indicate different substrates in the body such as 
lipids. A single voxel is a point in 3-dimensional space positioned within the area 
of interest used to determine the relative amounts of each substrate. The 
advantage of using spectroscopy is that it allows for relative amounts of various 
metabolites, most notably lipids, to be measured.  
A key advantage of administering a MR scan is that the MR does not emit 
ionizing radiation unlike X-rays and CT scans. Likewise, MR imaging of the brain, 
muscle, and ligaments/tendons results in higher quality images compared with 
other imaging technologies. Further, the MRS technique allows for metabolites in 
specific tissues to be assessed. Conversely, a major disadvantage of MR 
imaging is the high cost of the equipment and the need for highly trained 
personnel to operate the instrument. Due to the strong magnetic field that the MR 
emits, ferromagnetic items can be attracted into the MR scanner and are a risk to 
study personnel and the participant. Verbal screening and a hand-held metal 
detector can be used to ensure the participant has removed all ferromagnetic 
materials. Ferromagnetic implants and prosthetics are not compatible with the 
MRI. For example, pacemakers are an absolute contraindication to MR imaging; 
however, non-ferrous metallic implants may be imaged. Prior to scanning, details 
about body implants or any foreign body objects are documented and assessed 
to determine MR compatibility and safety. In addition, claustrophobic individuals 
may feel uncomfortable in an enclosed MRI; however new open MRI options are 
available although not all types of imaging are possible with an open MRI. During 
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the scan the electrical current in the wires of the 3 gradient magnets are opposed 
by the main magnetic field producing loud noise; therefore participants are 
provided with earplugs. Finally, the main cause of distorted images is motion 
artifact produced by the participant during scanning; therefore the individuals are 
asked to remain still for a prolonged period of time.  
In our study, MRI and MRS were used to measure EMCL and IMCL 
content in the gastrocnemius (Figure 2.1). We chose to image the gastrocnemius 
for its superficial anatomical location, which allowed us to combine MR 
technology with NIRS/DCS used to assess hemodynamics in superficial tissues 
[100]. With aging, a decline in muscle function and an increase in risk of fall were 
observed [101, 102]. The gastrocnemius is key to gait stability in aging. Likewise, 
age alterations in muscle lipid occur and often play a role in declining muscle 
function. By examining EMCL and IMCL in the gastrocnemius we were able to 
further the understanding of functional muscle decline with aging.  
Prior to scanning, all participants completed a MRI safety screening form 
(Appendix 1). Further, as dietary intake can influence muscle lipid content, 
participants were asked to refrain from eating overnight prior to scanning. 
Participants were positioned within a 3.0T TIM TRIO scanner (Siemens) in a feet 
first supine orientation with their lower leg (left or right), in a fixed dorsiflexed 
position, placed in a RF coil [59]. To minimize participant motion we taped the 
participant’s foot in a dorsiflexed position to the coil. If repeat MRI scans were 
completed, a small oil-filled capsule was taped to the calf muscle to ensure same 
anatomical slices were acquired on the repeated visit. The capsule location was 
41 
recorded by measuring the distance from the most inferior point on the 
participant’s heel to the middle portion of the capsule. In order to measure the 
anterior-posterior location we measured from the tibia to the middle of the 
capsule. At repeated scans the capsule was placed in the same location and 
served as a reference for slice positioning during imaging. T1-weighted images, 
non-fat and fat saturated, were completed and used to assess EMCL. 1H-MRS 
was used to quantify IMCL. In order to obtain IMCL data a single voxel placed in 
the gastrocnemius (TR/TE = 2,000/30 ms). In addition, an unsuppressed water 
spectrum of the same parameters in the single voxel was obtained (TR/TE = 
2,000/30 ms). To achieve optimal IMCL and EMCL peak separation 1) the voxel 
was placed within the gastrocnemius avoiding EMCL and 2) automated gradient 
and manual adjustments of the gradient were performed. Total imaging time was 
approximately 35 to 45 minutes. 
 Data was transferred from Siemen’s MR scanner to a Linux computer for 
quantification of IMCL and EMCL. LCModel (version 6.3, Stephen Provencher, 
Oakville, ON, Canada) was used to quantify IMCL using spectral fitting with water 
scaling and eddy current correction. LCModel was employed to estimate lipid 
peaks (1.5 ppm for EMCL CH2, 1.3 ppm for IMCL CH2, 1.1 ppm for EMCL CH3, 
0.9 ppm for IMCL CH3) and creatine (2.8 and 3.0 ppm) (Figure 2.2). IMCL 
methylene protons (1.3 ppm CH2), which were used for statistical analysis. 
LCModel automatically scaled lipids and creatine to unsuppressed water peak 
(4.7 ppm). Sets of T1-weighted images (TR/TE = 650/22 ms) for high-resolution 
anatomy were used to assess EMCL. Gastrocnemius EMCL was quantified by 
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manually drawn regions of interest (Figure 2.3) using a fat segmentation program 
(FSL View, FMRIB Software Library, version 5.0) and percent fat was calculated 
based on a mathematical formula published by Williams et al [103]. 
2.1.2 NIRS/DCS 
Skeletal muscle typically constitutes 40% of total body mass and during 
exercise skeletal muscle can use up to 85% of total cardiac output [104]. To 
maintain overall muscle function and health, microvascular blood flow delivers 
nutrients (e.g. oxygen) and removes by-products from the muscle [104, 105]. 
Hemodynamics explain forces that govern blood flow within blood vasculature 
and are integral in understanding tissue function and its ability to respond and 
adapt to stressors in both healthy and pathogenic muscle tissue [105]. Muscle 
tissue function can be evaluated through measurements of blood flow (BF), 
tissue oxygen consumption rate (VO2), and tissue oxygen saturation (StO2). 
These measures provide an additional parameter to the process of disease 
diagnosis and the ability to examine the efficacy of treatment.  
Currently, many different modalities exist to measure aspects of 
hemodynamics. MRI and Positron Emission Tomography (PET) scans are able 
to continuously monitor microvasculature changes during dynamic protocols 
[100, 104]. However, these instruments are relatively expensive and highly 
sensitive to motion during dynamic exercises, which distorts signals and 
produces motion artifacts. Another drawback is that these approaches require 
cumbersome equipment that is not portable and may not be available in all 
clinics. PET also requires the use of radioactive elements, which are harmful to 
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patients [104]. Another invasive technique is blood draws from major vessels 
through which blood gas levels can be determined. Measurements using this 
method yield regional rather than local results including partial pressure of 
oxygen, partial pressure of carbon dioxide, oxygen saturation, arterial pH, and 
bicarbonate levels. To further the understanding of tissue function and its 
adaptations to metabolic stress it is important to be able to measure 
hemodynamics in a continuous, non-invasive, and inexpensive way. 
Two novel and non-invasive optical technologies, NIRS and DCS, can be 
used to study healthy and pathogenic tissues by quantifying relative changes in 
the microvascular blood and measuring oxy- and deoxy-hemoglobin 
concentrations [104]. Tissue hypoxia is commonly associated with various 
disease states and can occur when arterial oxygen is low, blood flow is slow, or 
local tissue metabolism is high. Numerous medical conditions including 
cerebrovascular accidents (CVA), peripheral artery disease (PAD), and even 
some cancers are associated with anomalies in hemodynamics. PAD is the 
narrowing of peripheral arteries primarily in the lower limbs and does not 
encompass the blood supply to the heart or brain. Vascular deficits are the 
keystone in PAD patients and to some extent PAD patients have a poor 
response to the metabolic demands of exercise. Following treadmill and pedal 
exercise tests, an increase in relative blood flow (rBF) was observed in healthy 
subjects, whereas PAD patients maintained relatively stable rBF [106]. Likewise, 
the effect of fibromyalgia on the microvasculature was investigated by 
NIRS/DCS. Fibromyalgia is characterized as the widespread musculoskeletal 
44 
pain typically accompanied by reduced exercise tolerance, fatigue, sleep 
deprivation, memory impairments, and mood disorders [107, 108]. Patients with 
fibromyalgia had similar rBF with matched healthy controls; however lower 
oxygen extraction was observed in the disease state [107]. These data highlight 
the importance of monitoring multiple parameters to provide measures of local 
muscle metabolism and the advantage of the novel and non-invasive nature of 
NIRS/DCS. 
NIRS oximetry is a reliable instrument used to determine oxy-hemoglobin 
(HbO2), deoxy-hemoglobin (Hb), total hemoglobin concentration (THC), and 
blood oxygen saturation (StO2) [100]. Advantages of NIRS include the ability to 
assess tissue hemodynamics in a non-invasive continuous manner, monitor at 
the bedside due to its easy portability, and penetrate tissue up to several 
centimeters in depth. A well-known spectral window exists in NIRS (650-950nm), 
in which tissue absorption is relatively low, allowing light to penetrate into 
deep/thick tissue [105]. As photons pass through the tissue the photons scatter 
when interacting with cell membranes, organelles, and nuclei or be absorbed 
when interacting with HbO2 and Hb. At NIRS wavelength the scatter is greater 
than the absorption and the photons will reflect back to the surface of the tissue 
in which a detector can sense the photons. Three different techniques of NIRS 
exist and differ in illumination type. The three paradigms are 1) continuous-wave, 
2) frequency domain, and 3) time-domain. We use frequency domain in which 
the inputted modulated light interacts with the tissue, such as the muscle, and the 
change in amplitude and phase shift are detected. Measurements of these 
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changes at multiple source-detectors allow for the quantification of absolute 
values of deoxy-, oxy- and total hemoglobin concentrations [i.e. [Hb], [HbO2], 
and [THC].   
DCS is used to quantify changes in microvascular rBF in deep tissues. 
Previously, only red blood cells in superficial tissue (<1mm) were able to be 
monitored by laser Doppler. This technique utilized the single scattering theory, 
which quantified the light fluctuations within a specified tissue area. However, in 
deeper or ticker tissues the photons undergo multiple scattering that are 
accounted for by the DCS. DCS uses near-infrared light to penetrate deep 
tissues and measure light speckle fluctuations caused by the motion of red blood 
cells [104]. Unlike other modalities for measuring BF in which a patient may be 
exposed to ionizing radiation or contrast agents (eg. PET), DCS is non-invasive. 
Most importantly it can be utilized for continuous monitoring during dynamic 
exercise when a gating algorithm is applied.  
 Separately these two sophisticated tools can be used to monitor 
oxygenation and BF in tissues. However, in combination, hybrid NIRS/DCS 
instrument can be used to derive relative oxygen consumption (rVO2) employing 
Fick’s principles [100]. Although Fick’s principles were initially developed for 
measuring cardiac output, the principles can be applied to procure other 
quantifications. Fick’s principles include knowing 1) how much of a substance is 
consumed by the tissue per unit of time, 2) how much of the substance is in the 
arterial blood supply to the tissue, and 3) how much of the substance is in the 
venous blood leaving the tissue. Fick’s law states that the BF multiplied by the 
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arteriovenous oxygen difference is equaled to rVO2. Using NIRS/DCS and 
employing Fick’s laws, rVO2, relative oxygen extraction fraction (rOEF), and 
relative BF (rBF) can be derived. Recently, the combination of the hybrid 
NIRS/DCS instruments were used to continuously monitor hemodynamic 
parameters during a handgrip exercise in forearm muscles [109]. These 
methodologies were modified and applied to the gastrocnemius, a lower-limb 
muscle, during a dynamic plantar flexion exercise [100].  
In my study, NIRS/DCS was used to quantify muscle oxygen consumption 
rate (VO2), BF, and tissue (muscle) oxygen saturation (StO2) in the 
gastrocnemius during a plantar flexion exercise protocol (Appendix 2). A plantar 
flexion exercise is the ankle movement of moving the foot down and pointing the 
toes away from the body. A commercial NIRS oximeter (Imagent, ISS inc.) and a 
custom built DCS flowmeter were used. The Baltimore Therapeutic Equipment 
(BTE Primus, Hanover, MD) was used for the plantar flexion exercise. 
Participants were seated at a 70° semi-recumbent position with the right calf 
exposed for placement of the optical spectroscopy sensors. The right foot was 
placed into the BTE plantar flexion attachment and secured with Velcro straps. 
Participants completed a familiarization session followed by a testing session and 
were given at least 48 hours of rest between these two sessions to avoid the 
influence of muscle fatigue on tested measures. During familiarization and testing 
sessions a warm-up was implemented to prime the body for increased oxygen 
demand occurring with exercise and to reduce the risk of injury. Warm-up 
consisted of at least 10 foot plantar flexion repetitions at 30º range of motion and 
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a torque of 25% of bodyweight. Next, at least 5 maximal voluntary isometric 
contractions (MVC) lasting 4-5 seconds were completed with a 30 second rest 
period between each MVC  [110]. Thirty-five percent of the highest MVC 
recorded was used to set torque that the participant pushed against during a 75 
foot plantar flexion repetition exercise [100]. To ensure consistent effort was 
provided by the participants during MVC, additional MVC were performed if 
coefficient of variation (CV) was greater than 10%.  
After MVC was determined, the optical sensor was taped to the right 
gastrocnemius. Right thigh occlusions were performed and used to calibrate the 
NIRS/DCS device to obtain absolute baseline BF (ml/100ml/min) and absolute 
baseline VO2 (ml/100ml/min). Occlusions consisted of three, 10 second venous 
occlusions at 55 millimeter of mercury (mmHg) which blocked the return of blood 
flow to the heart from the lower limb. One minute recovery periods between 
venous occlusions were completed. Data from venous occlusions were used to 
calibrate rBF (measured by DCS). Next, one, 3 minute arterial occlusion at 235 
mmHg was completed and used to calibrate rVO2 to absolute VO2, with 5 
minutes of recovery time (measured by NIRS). A 3 minute arterial occlusion 
allowed for complete occlusion of blood flow into and out of the lower limb. 
Recovery periods allowed tissue hemodynamics to return to baseline [100, 110].  
Muscle BF, StO2, and VO2 rates were continuously measured 3 minutes 
before the plantar flexion exercise to ensure hemodynamic stability, during the 75 
plantar flexion repetitions (2.5-3 minutes), and for 15 minutes post-exercise to 
monitor blood flow recovery. Participants were asked to complete the concentric 
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plantar flexion contractions and the plantar flexion attachment automatically 
completed the eccentric dorsiflexion contractions without participant assistance. 
Verbal encouragement was used to ensure consistent effort throughout the 75 
repetitions. NIRS/DCS instrument collected local muscle tissue parameters 
(VO2, BF, and StO2) at the end of every eccentric phase plantar flexion (0.5s 
measurements period) to minimize muscular motion artifacts due to muscle 
contraction. These procedures were adapted from Henry et al. [100], in which 
NIRS/DCS measures were translated from examining hemodynamic measures in 
the forearm muscle during handgrip exercises to the gastrocnemius muscle 
during plantar flexion exercise.  
2.2 Clinical Assessments 
Participants’ height, weight, blood pressure, and waist circumference were 
measured. The study coordinator measured participants’ height using a wall-
mount stadiometer (DETECTO 3P, Webb City, MO or SECA 264). To ensure 
precise measurements participants were directed to remove their shoes, hair 
jewelry, hats or hairstyles such as buns or braids from the top of their heads and 
stand on the stadiometer platform [111]. Participants were further instructed to 
stand up straight against the backboard of the stadiometer and to the best of 
their ability keep their head, shoulder blades, buttocks, and heels in contact with 
the backboard. The head was aligned in the Frankfort horizontal plane, in which 
the ear canal and the eye were parallel to the floor and perpendicular to the 
backboard. Next, the participant was instructed to take a deep breath and hold 
this position as the coordinator lowered the headpiece of stadiometer to rest 
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firmly on top of the participant’s head compressing the hair. Measurements were 
obtained one time and recorded in centimeters. Weight was determined using a 
Tanita 800S scale (Tokyo, Japan). Participants were instructed to remove shoes 
and any objects in pockets. The study coordinator calibrated the scale to zero 
and instructed the participant to step and stand still on the scale platform. Once 
the readout on the digital scale became stable the coordinator recorded the value 
in kilograms. Body mass index (BMI) values were calculated using measured 
height and weight values as weight (kilograms)/height (meters2). BMI categories 
were defined as: underweight (BMI value <18.5), normal weight (BMI value 18.5-
24.9), overweight (BMI value 25-29.9), obese class I (BMI value 30-34.9), and 
obese class II (BMI value 35-39.9) and extremely or morbidly obese (BMI value 
≥40) [111, 112].  
The study coordinator obtained blood pressure using a standard 
(16centimeters (cm) width; 30cm length) or large adult (16cm width; 36cm length) 
automatic blood pressure cuff. The participant was in a seated position with the 
arm uncovered and the cuff placed on either the right or left arm approximately 
2cm above the bend in the elbow [113]. The center of the inflatable portion of the 
cuff was positioned over the brachial artery and the cuff was at heart level. 
Participants were asked to place both feet flat on the floor and sit silently during 
blood pressure measures. The study coordinator recorded the systolic and 
diastolic values (mmHg). 
Waist circumference (Gulick II Measuring Tape, Wisconsin, USA) was 
measured by the study coordinator three successive times and the results were 
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averaged. The inelastic, flexible tape measurer was placed on bare skin surface 
without compressing the subcutaneous adipose tissue [114]. The smallest 
circumference above the umbilicus and below the xiphoid process was used for 
tape measure placement. The participants were asked to stand still, cross their 
arms and place their hands on the opposite shoulders. The participants were 
instructed to breathe normally and measurements were recorded at the end of a 
normal exhalation [111, 114].  
Registered nurses, licensed practical nurses and phlebotomists at the 
Center for Clinical and Translation Sciences at the University of Kentucky 
completed all blood draws [115]. Prior to blood draw, participant’s identification, 
name and date of birth, were verified and the participant sat in a comfortable 
position. The tourniquet was placed approximately 3-5 inches above the 
venipuncture site on either the left or right arm. A winged infusion set, butterfly 
clip, was used on either the antecubital area or if arm vein attempt was not 
successful on the dorsal surface of the wrist. If the individual collecting the 
specimen did not obtain an appropriate specimen after two attempts the 
assistance of another staff member was requested. A gold top tube (3.5ml) was 
used to collect serum and 25(OH)D, the sum of 25(OH)D2 and 25(OH)D3, was 
analyzed by liquid chromatography/tandem mass spectrometry with a CV of 
10%. The University Biospecimens Core of the Center Clinical and Translational 
Science completed all blood analysis.  
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2.3 Medical History Questionnaire  
A non-validated medical history questionnaire was administered 
(Appendix 3). The questionnaire inquired about prescription drugs and any over-
the-counter medications including dietary supplements. In addition, current and 
past smoking status, allergies, chronic illnesses or viruses, past surgeries, and 
family history of pulmonary, metabolic disease, stroke or sudden death were 
documented. The questionnaire also inquired about any other reasons why the 
participant should not take part in physical activity (eg. neuromuscular or 
metabolic disorders, breathing issues, asthma, or emphysema). Finally, 
participants were asked if they were currently seeing their healthcare provider for 
any reason and if applicable to provide further explanation. 
2.4 Socioeconomic Status Questionnaire 
A series of questions that inquired about participant’s socioeconomic 
status (SES) was administered [116]. The SES questionnaire inquired about 
educational attainment, household size, annual household income, and current 
and past employment status. This information was collected in order to examine 
the extent to which differences in SES may play a role in vitamin D status, 
physical activity levels, and dietary intake.   
2.5 Diet Assessment 
Participants were asked to continue regular dietary intake throughout the 
study. Personnel (interviewer) trained in the use of nutrition research software 
conducted an interview by phone to complete a 24-hour dietary recalls on two to 
three non-consecutive days. The recalls were obtained on at least one weekend 
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and one weekday to account for variance in caloric intake based on the day of 
the week [117]. The Nutrition Data System for Research (NDS-R, Version 2015, 
University of Minnesota, Minneapolis, MN) was used to obtain and analyze 
dietary intake [118].  
The NDS-R system employs the multiple-pass method to ensure the 
validity and reliability of the dietary data [117, 119]. The multiple-pass method 
refers to a standardized five-step procedure designed by the United States 
Department of Agriculture to minimize the occurrence of misreporting and various 
forms of bias by confirming food items and portion sizes throughout the interview 
[117, 119, 120]. The first pass involved obtaining a list of all foods and beverages 
consumed in the previous 24 hours. During the second pass the list was 
reviewed with the participant for completeness and correctness. Third, the 
interviewer collected all details about each reported food and beverage item, 
including method of preparation and amount consumed. Fourth, the interviewer 
probed for commonly forgotten foods, such as snacks or beverages consumed 
throughout the day. Lastly, the detailed information was read back to the 
participant and reviewed for completeness and correctness [121]. In addition, the 
participant was asked if the amount of food they consumed in the previous 24 
hours was equal to, greater than, or less than the amount typically consumed. 
Likewise, information on any dietary supplements consumed (type and dose) 
was recorded. 
The NDS-R database includes over 18,000 foods and 8,000 brand name 
products [121]. Further this system provides the ability to account for differences 
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in food preparation methods, which allows for a complete and thorough dietary 
recall. Values for nutrients and nutrient ratios were generated by the database 
and used to assess the relationship between dietary intake and muscle lipid. 
2.6 Physical Activity Assessments 
Participants wore an ActiGraph GT3X monitoring device (Actigraph, 
Pensacola, FL), a reliable and valid tool to measure physical activity in older 
adults [122]. Participants were instructed to wear the device on a belt over their 
non-dominant hip for seven consecutive days. Participants were instructed to 
remove the accelerometer before bathing or participating in any other water 
based activity and before sleeping.  
The device is lightweight (27g), small (3.8x3.7x1.8cm) with a rechargeable 
battery [123]. The device is tri-axial and able to detect and collect data on 3 axis: 
horizontal right to left (X), vertical (Y), and horizontal front to back (Z). Data is 
collected using a time sampling interval (epoch) of 10 seconds, which Actigraph 
software outputs as counts. These counts were linearly related to the intensity of 
the participant’s physical activity levels and were derived from vector magnitude 
(VM) defined as √X2+Y2+Z2. We based our definition of sedentary, moderate, 
and vigorous physical activity in older adults on previously valid and reliable VM 
cut-off points developed by Santos-Lozano et al [123]. Sedentary or inactivity, 
such as sitting, ironing, laundry, washing dishes, and cooking, was identified as a 
VM cut point of <2751, which amount to <3 metabolic equivalents (METs). MET 
is defined as the amount of oxygen consumed during a specific activity. One 
MET is defined as the amount of oxygen consumed while sitting quietly in a chair 
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and is equivalent to 3.5ml/kg/min [124]. Moderate activity (3-6 METs) was 
defined as 2751 to 9359 (VM) which included activities such as window washing, 
vacuuming, gardening, yard work, or recreational activities. Activities such as 
biking or running, with a VM >9359, were considered vigorous (>6METs).  
The ActiLife 6 software was used to analyze all data (version 6.11.9). Data 
from the ActiGraph provided detailed information regarding daily physical activity 
and length of time (minutes) that each participant spent at various levels of 
physical intensity. Meeting the Center for Disease Control guidelines on physical 
activity was defined as engaging in an average of >30minutes/weekday of 
moderate aerobic activity [125].  
A Physical Activity Scale for the Elderly (PASE) questionnaire was 
administered to obtain a self-reported measurement of occupational, household, 
and leisure activities during the previous 7 days. Activity items required 
participants to report the number of days per week the activity was performed 
followed by the number of hours per day. Study personnel scored the 12-item 
questionnaire based on instructions published by The New England Research 
Institutes in which greater reported activity levels were associated with higher 
scores [126]. Total score were used for statistical analysis and typically ranged 
from 0 to 400. Validity and reliability of the PASE questionnaire has been 
previously established in individuals older than 65 years of age (Table 2.2) [126, 
127].    
Participants also completed the Physical Activity Readiness Questionnaire 
(Appendix 4) [128], American Heart Association/American College of Sports 
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Medicine Facility Preparticipation Screening Questionnaire (Appendix 5) [129], 
and an un-validated physical activity habits survey (Appendix 6) inquiring about 
the frequency, duration, and type of physical activity. 
2.7 Physical Functional Assessment 
The Four Square Step Test (FSST) was established as a reliable and valid 
tool used to test dynamic balance and mobility in adults over 65 years of age 
[130]. The test is quick to administer and requires no special equipment. It is both 
a sensitive and specific measure that can be used to discern between older 
adults that have experienced falls compared with non-fallers. 
The FSST required participants to move in different directions and step 
over a one-inch obstacle on the floor (Figure 2.4). An exercise physiologist 
instructed participants to step over a plastic pipe lying flat on the ground for each 
of the following directions: 1) forward, 2) sidestep to the right, 3) backwards, and 
4) sidestep to the left. This was repeated in the opposite direction and the total 
time to complete the task was recorded. Participants completed one practice trial 
to become familiarized with the test followed by three test trials. Only the fastest 
test trial was used for data analysis. A cut-off score of greater than 15 seconds 
for completion was used to indicate a greater risk for multiple falls for adults 
greater than 65 years of age [130].  
2.8 Graded Exercise Test (GXT) 
A multi-stage GXT was used for the assessment of respiratory and 
circulatory function using Vmax Encore (Carefusion, Yorba Linda, CA). This test 
was commonly used at University of Kentucky for sedentary or aged individuals 
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and included a progressive 2-minute workload stages (Table 2.3, Appendix 7). At 
the final minute of each stage, heart rate, blood pressure, and rate of perceived 
exertion (RPE) were recorded. During the test, breath-by-breath measurements 
of oxygen consumption and continuous 12-lead electrocardiogram (EKG) were 
monitored.  
VO2max is defined as the maximal rate of oxygen uptake during maximal 
exercise [131]. When the oxygen uptake plateaus and does not increase by more 
than 150ml/min with further increases in workload, VO2max is reached. 
However, many individuals do not reach the oxygen uptake plateau and 
additional criteria for VO2max may be used to indicate if a true VO2max has 
been reached. Additional criteria were the following: failure of heart rate to 
increase with increases in exercise intensity, venous lactate concentrations ≥8 
mmol/L, respiratory exchange ratio ≥1.1, and RPE≥17 on the original Borg scale 
(6-20). VO2 peak is the greatest rate of oxygen consumption measured during 
the test regardless if a plateau is reached. VO2 peak can be higher, lower, or 
equal to VO2max. Many individuals do not reach their true VO2max as oxygen 
uptake does not plateau; however VO2 peak attained during a maximum effort 
treadmill test, such as our GXT, is a valid index of cardiorespiratory fitness [131]. 
Normative data for VO2max in older adults are depicted in Table 2.4 [131]. 
Participants were closely monitored and verbal encouragement was provided 
throughout the test. Upon completion of the GXT, recovery (cool-down) exercise 
was performed for at least 5 minutes or until heart rate was <100 beats per 
minute. Test termination was based on volitional fatigue or the presence of any 
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absolute or relative contraindications according to the American College of 
Sports Medicine Guidelines [114]. A trained exercise physiologist performed all 
testing and a physician reviewed all medical history prior to testing and post-GXT 
results for contraindications to study participation.  
2.9 Aerobic Training 
For 7 consecutive days, participants randomized to an aerobic training 
protocol performed up to 45 minutes of treadmill exercise (Landice Cardio, 
Randolph, NJ). Training protocol was based on a previous protocol implemented 
in a similar population [74]. The exercise consisted of treadmill walking at a 
progressive intensity of about 60-65% of their maximum heart rate (maximum 
heart rate = 220 - age). During each exercise session participants had their blood 
pressure measured before and after the exercise. Participants wore a heart rate 
monitor to monitor their individualized target heart rate and maintain intensity. As 
an added safety measure participants were allowed to significantly reduce their 
training intensity to a slow walk for 5 minutes at any time they requested. Each 
training session incorporated a brief standardized warm-up and cool down. The 
study coordinator supervised every session and compliance with all training 
sessions was carefully documented (Appendix 8).  
2.10 Body Composition 
Body composition changes occur with aging often without body weight or 
BMI changes [132]. Generally, fat mass increase and lean mass and bone 
mineral density (BMD) decrease are observed with aging. Further, the changes 
in fat mass distribution occur during aging with a greater accumulation of fat in 
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the abdominal region. Numerous body composition instruments and techniques 
can be used to measure body composition; however, DXA and CT imaging 
provide a sophisticated approach to quantify fat and lean mass [97]. Traditionally, 
DXA scans were clinically used to monitor osteopenia/osteoporosis, but both 
DXA and CT scans can also be used to estimate fat and lean tissue content in 
total body or body segments. Further, CT scans can provide a cross-sectional 
image of visceral fat and fat infiltration in lean tissue. 
2.10.1 DXA Imaging 
The DXA scan is a highly preferable method used in research due to its 
ability to estimate bone mineral density, fat and lean soft tissue content in an 
expedient scanning time with minimal cooperation from the participant [131]. The 
imaging is dependent on the attenuation of the X-ray through various tissues that 
differ in their densities and chemical composition. DXA body composition 
assumptions include that 1) a constant attenuation of pure fat and bone-free lean 
tissue was maintained, 2) measurements were not affected by anteroposterior 
thickness, 3) the composition of each body region was equally represented in the 
calculation of total body values, and 4) that one tissue was analyzed at a time.  
A DXA scan was performed at the CCTS by a study personnel trained in 
this procedure. A total body DXA scan was performed using a Lunar Prodigy (GE 
Lunar Inc., Madison, WI) bone densitometer. Participants were instructed to 
remove all objects such as jewelry or eyeglasses and wear a hospital gown or 
light-weight clothing (containing no metal) during the scanning procedure. The 
scans took approximately 8-10 minutes. Scans were analyzed using the GE 
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Lunar software (version 10.0). Total body, regional fat and fat-free mass (FFM; 
kg), mineral-free lean (MFL; kg) mass, and the appendicular skeletal muscle 
index were assessed.  
2.10.2 CT Imaging 
A subsample of participants completed a CT scan and all scans were 
administered and results analyzed by trained personnel. Single slice CT images 
(Siemens) were used to quantify skeletal muscle and fat area of both right and 
left thighs and abdominal visceral fat. A 100 milliampere (mA) tube current with a 
3 second scanning time was chosen to produce quality images while limiting 
exposure time of the radiation to the participant. CT image was composed of a 
512x512 square matrix resulting in 262,144 pixels (512x512=262,144). The 
attenuation coefficient is the measure of how easily the beam can go through the 
material being imaged [133]. The pioneer of CT scanner, Godfrey Hounsfield, 
created an attenuation scale to characterize the densities of air, fat, water, and 
bone. In our study we used a modified version of the Hounsfield scale, in which 
tissue area was quantified using the corresponding attenuation values: bone 
≥200 Hounsfield Unit (HU); adipose tissue -190 to -30 HU; and skeletal muscle 0-
100 HU. With participants in a supine position, mid-thigh measures were 
completed with a mark between the inguinal crease and the proximal border of 
the patella. Total thigh fat was further subdivided into two compartments 
including the fat above the fasica latae (subcutaneous thigh fat) and below the 
fascia latae (deep thigh fat). In addition, the skeletal muscle was subdivided into 
areas of low attenuation (0-34 HU) representing fat rich muscle, and high 
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attenuation values (35-100 HU) representing muscle with normal fat content. The 
software by the National Institutes of Health Image Processing and Analysis in 
Java was used to analyze all data [134].   
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Table 2.1 Advantages and disadvantages of MRI, DXA, and CT in vivo imaging 
 
Method Advantages Disadvantages 
MRI -no ionizing radiation 
-assessment of muscle 
quality 
-quantify muscle 
compartments and fat depot 
(IMCL & EMCL) 
-expensive 
-not widely available 
-scanning and image analysis 
requires trained personnel 
-no gold standard in scan and 
analysis protocols  
DXA -widely available in clinical 
settings 
 
-low dose exposure to ionizing 
radiation  
-no assessment of muscle 
quality 
CT -widely available in clinical 
settings 
-assessment of muscle 
quality 
 
-low dose exposure to ionizing 
radiation 
-lower reproducibility and 
reliability compared with MRI 
-no gold standard in scan and 
analysis protocols 
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Table 2.1 Advantages and disadvantages of MRI, DXA, and CT in vivo imaging 
The table outlines advantages and disadvantages of various imaging 
technologies. 
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Figure 2.1 T1-weight MRI axial image of the calf muscle 
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Figure 2.1 T1-weight MRI axial of the calf muscle 
Right calf T1-weighted transverse slice image. Major muscles and bones 
were identified and labeled. To further allow for better peak separation between 
EMCL (-CH2) and IMCL (-CH2), gastrocnemius voxel was placed to avoid 
extramyocellular fat depots. Participant was a 66 year old Caucasian male with a 
BMI of 26.8 kg/m2. 
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Figure 2.2 1H-MRS spectrum of the gastrocnemius muscle to assess IMCL 
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Figure 2.2 1 H-MRS spectrum of the gastrocnemius muscle to assess IMCL 
1H-MRS spectrum of the human gastrocnemius muscle fitted using 
LCModel (dark trace is the raw data; red trace is the fitted spectrum, and trace at 
top of figure is the residual). Participant was a 73 year old Caucasian female with 
a BMI of 22.2 kg/m2. IMCL (-CH3), methyl protons at 0.9 ppm; EMCL (-CH3), 
methyl protons at 1.1 ppm; IMCL (-CH2), methylene protons at 1.3 ppm; EMCL (-
CH2), methylene protons at 1.5 ppm; creatine (-CH3) resonance at 3.0 ppm. 
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Figure 2.3 Highlighted regions of interests in the gastrocnemius to assess EMCL 
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Figure 2.3 Highlighted regions of interests in the gastrocnemius to assess EMCL 
Gastrocnemius muscles were manually segmented (highlighted in red) 
from each axial image producing a transverse planar image (only 1 image of 15 
are depicted). Participant was 64 year old Caucasian female with a BMI of 
19.1kg/m2.  
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Table 2.2 The New England Research Institutes’ PASE scores by age group and 
sex 
 65-69 YO 70-75 YO 76-100 YO 
Males 144.3±58.6 102.4±53.7 101.8±45.7 
Females 112.7±64.2  89.1±55.2 62.3±50.7 
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Table 2.2 The New England Research Institutes’ PASE scores by age group and 
sex 
The New England Research Institutes established the validity and 
reliability of the PASE questionnaire [126]. Community-dwelling adults 65-100 
year of age (n=222) were recruited. Higher PASE scores were significantly 
correlated with greater performance measures and overall health status. The 
mean±SD for age categories between sexes are presented. 
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Figure 2.4 Four Square Step Test 
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Figure 2.4 Four Square Step Test 
 The FSST is an inexpensive tool used to measure physical function in 
older adults. The participant was instructed to stand in square 4 and step over a 
1-inch obstacle to square one. The participant continued as fast and safely as 
possible stepping into each square in the following sequence: 4, 1, 2, 3, 4, 5, 6, 
7, and 8.  
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Table 2.3 GXT 
Stage Time (min) Speed (mph) Gradient (%)  
1 0-2 2.2 0 
2 2-4 2.6 0 
3 4-6 3.0 2 
4 6-8 3.4 4 
5 8-10 3.8 6 
6 10-12 4.2 8 
7 12-14 4.6 10 
8 14-16 5.0 12 
9 16-18 5.4 14 
10 18-20 5.8 16 
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Table 2.3 GXT 
Table describe the duration, speed, and grade of each stage. 
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Table 2.4 Cardiovascular fitness classifications: VO2 max (ml/kg/min) 
Age (yr) Poor Fair Good Excellent  Superior 
Females 
60-69 ≤25 26-28 29-31 32-36 37+ 
70-79 ≤23 24-26 27-29 30-36 37+ 
Males 
60-69 ≤30 31-34 35-38 39-45 46+ 
70-79 ≤27 28-30 31-35 36-41 42+ 
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Table 2.4 Cardiovascular fitness classifications: VO2 max (ml/kg/min) 
Table describes the cardiorespiratory fitness classification for females and 
males, 60 to 80 years of age.  
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Chapter 3: Specific Aim 1 
3.1 Summary 
A high prevalence of vitamin D deficiency and insufficiency has been 
documented in older adults. It has been well established that vitamin D is linked 
to bone health, but more recently, there is a growing interest regarding the 
relationship between vitamin D and muscle health. With aging, muscle health 
declines and changes in muscle lipid depots occur. PURPOSE: The objective of 
this retrospective trial was to examine the relationship between 25-hydoxyvitamin 
D (25(OH)D) concentrations, muscle lipid depots (intramyocellular lipid (IMCL) 
and extramyocellular lipid (EMCL)), and physical function. We aimed to examine 
if muscle lipid depots and 25(OH)D concentration were different between 
individuals of varied BMI and physical activity levels. METHODS: Data from 
adults 60 years of age or older who completed cross-sectional studies between 
2012 and 2016 were combined. Blood was drawn to determine 25(OH)D 
concentrations and at least one form of physical activity assessment was 
completed (Actigraph accelerometry, Physical Activity Scale for the Elderly 
(PASE) or physical activity questionnaire). Anthropometrics measures included 
height, weight, waist circumference, dual-energy X-ray absorptiometry (DXA), 
and computed tomography (CT) scans. Gastrocnemius IMCL and EMCL were 
measured with magnetic resonance spectroscopy (MRS) and fat segmentation, 
respectively. Pearson correlations and independent student t-test were 
employed. RESULTS: Fifty-five participants took part in the 3 studies and a 
subsample completed waist circumference (n=42) and the Four Square Step 
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Test (FSST) (n=31). Eighteen of the 31 participants that completed the FSST 
also completed DXA and CT scans. In the total sample, mean age and body 
mass index (BMI) were 70.8±6YO and 25.9±4kg/m2, respectively. A significant 
negative relationship was observed between 25(OH)D and EMCL (p=0.02). IMCL 
was positively correlated with 25(OH)D concentrations (p=0.008). As BMI 
increased, a general decrease in 25(OH)D concentrations and increase in IMCL 
and EMCL was observed, but did not reach statistical significance. In females 
only, greater 25(OH)D concentrations were significantly correlated with faster 
FSST times (p=0.007). In addition, 25(OH)D concentrations and EMCL (p≤0.01) 
were significant predictors of FSST when including BMI (p=0.558) and age 
(p=0.163) in the model. CONCLUSIONS: Previous studies have observed 
significant relationship between vitamin D status, BMI, and muscle lipid depots. 
In accordance with previous literature, we found a relationship between vitamin D 
status, muscle lipid, and physical function. Discovering that vitamin D status and 
EMCL predict physical function independent of age and BMI in healthy older 
adults is novel. Studies suggest a relationship exists between muscle lipid 
depots, BMI categories, vitamin D status, and exercise; however further data is 
needed to examine to what extent vitamin D repletion plays a role in muscle 
health and function in vitamin D deficient older adults. 
3.2 Introduction 
 In developed nations, vitamin D deficiency and insufficiency have become 
a worldwide epidemic and a particular concern in older adults. It is difficult to 
obtain sufficient vitamin D status through dietary intake alone; therefore, this 
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epidemic can be primarily attributed to inadequate sun exposure and prolonged 
time spent indoors without dietary supplementation [27]. Likewise, an increase in 
adiposity has been related with decreased vitamin D status [41, 42]. In addition, a 
reduction in the quantity of 7-dehydrocholesterol, the precursor of vitamin D, is 
observed in aging skin, further contributing to lower vitamin D status in older 
adults [28]. Studies reported that 20-100% of older adults were vitamin D 
deficient [27, 50]. The wide variance in vitamin D deficiency is due to non-
standardized definitions of several factors including: vitamin D cut-off levels, 
methodology for vitamin D concentration assessment, and age cut-offs used. The 
National Institutes of Health set vitamin D deficiency (measured as 25(OH)D) as 
<20ng/mL, which in healthy individuals is generally considered to be inadequate 
for both bone health and overall health [26, 27].  
Beyond bone health, research suggests that greater 25(OH)D 
concentrations may be necessary to maintain muscle health [6, 24, 44, 45]. 
Lower 25(OH)D concentrations were associated with reduced muscle strength 
and performance-based functional outcomes in the older adults [49, 50, 66]. 
Vitamin D supplementation trials have yielded mixed results primarily due to 
varied study designs [49]. However, some low-dose vitamin D supplementation 
trials, in deficient older adults, have shown improvements in muscle strength and 
decreases in body sway [135, 136].  
The mechanism in which vitamin D supplementation beneficially effects 
skeletal muscle is still under investigation. Vitamin D can bind to the vitamin D 
receptor (VDR) located on the muscle cell and act through both genomic and 
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non-genomic pathways. These pathways contribute to the regulation of calcium 
and muscle contractions, and an increase in quantity and size of Type II muscle 
fibers [65, 66, 71]. Further, vitamin D has been associated with the quantity of 
lipid found in muscle lipid depots, which play a role in muscle metabolism and 
function [55, 59]. Muscle lipid depots are categorized as IMCL and EMCL. IMCL 
is located within the muscle cell, typically in close proximity to the mitochondria 
where the lipid can be readily oxidized during increased metabolic muscle 
demands [72]. High IMCL content has been associated with greater insulin 
resistance in obese, sedentary individuals. Paradoxically, in active individuals, an 
increase in insulin sensitivity has been observed with high IMCL content [77]. 
EMCL is adipose tissue that has infiltrated the skeletal muscle and is located 
between muscle fibers [82]. EMCL accumulation is thought to play a negative 
role in muscle health, as reduction in physical function is observed with greater 
EMCL content [74, 79, 84, 85].  
Vitamin D deficiency has been linked to greater EMCL and reduced 
muscle strength [50, 55, 66, 86]. In older adults, impaired gait and balance were 
associated with lower vitamin D status and greater EMCL [55]. Recently, our lab 
observed no relationship between vitamin D status and EMCL, but a positive 
linear relationship was observed between vitamin D status and IMCL, 
independent of reported physical activity and BMI [59]. Although muscle lipid was 
not associated with the FSST, a measure of functional performance, we 
observed a relationship between greater 25(OH)D concentrations and faster 
FSST. These associations may be party explained at the cellular level with lipid 
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depot alterations that occur with aging. In C2C12 myotubes, the addition of 
calcitriol increased the expression and concentration of VDR, lipid packaging 
proteins, and a protein (OXPAT) that promotes fatty acid utilization [66, 81]. 
Together these data may suggest that vitamin D is involved in the packaging and 
mobilization of IMCL. 
In addition to 25(OH)D concentrations, modifiable factors including 
exercise and adiposity contribute to altering the quantity of muscle lipid depots. In 
obese adolescents, an increase in IMCL, fitness, and power was observed after 
an 8 week exercise intervention. IMCL increases were associated with increased 
resting energy expenditure and a lower respiratory quotient suggesting greater 
lipid oxidation [94]. In older sedentary adults, high IMCL content was observed 
and associated with decreased force, power, and slower skeletal muscle 
contractions [80]. Conversely, in older insulin resistant obese men who engaged 
in 7 consecutive days of aerobic training, an increase in IMCL and decrease in 
EMCL with concurrent improvements in insulin sensitivity was observed [74]. 
These studies show that exercise can lead to altered muscle lipid depots and  
insulin sensitivity.   
Adiposity is another modifiable factor that can plays a role in muscle lipid 
depots changes. One study found that central obesity was associated with 
greater IMCL and EMCL content, independent of age [79]. Velan et al. [84] 
observed a proportional increase between weight categories (normal weight, 
overweight, and obese) and both muscle lipid depots (IMCL and EMCL) in adults. 
These studies suggest that adiposity is related with muscle lipid depot 
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accumulation; however, the relationship between adiposity, vitamin D status, 
muscle lipid content, and physical function outcomes have not fully been 
investigated.  
The objective of this retrospective trial was to examine the relationship 
between vitamin D status, muscle lipid depots (IMCL and EMCL), and physical 
function in adults 60 years of age or older. Further, we examined the influence of 
adiposity on these relationships. Finally, we describe muscle lipid depots and 
25(OH)D concentrations differences between individuals of varied BMI and 
physical activity levels.   
3.3 Methods 
3.3.1 Participants 
Individuals 60 years of age or older were recruited to participate. These 
individuals resided in Southeastern United States (latitude 38°N). Exclusion 
criteria included inability to walk up a flight of stairs without assistance, diabetes, 
history of kidney disease, neurologic disorders, and myopathy. Additional 
exclusion criteria included lower extremity injury or surgery and the initiation of a 
resistance or aerobic training exercise regimen in 3 months prior to study 
enrollment. Individuals with ferromagnetic implants or foreign bodies that were 
magnetic resonance imaging (MRI) incompatible were not eligible to take part in 
the study. The university institutional review board approved this study. Written 
consent was obtained from all participants prior to study measures. Institutional 
and governmental regulations concerning human participants in research were 
followed including study data collection and management. Research Electronic 
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Data Capture tool (REDCap) [137] was used for study data. REDCap is a secure, 
web-based application designed to support data capture for research studies 
hosted at the University of Kentucky. 
3.3.2 Study Design 
Participants completed visits between 2012-2016 (Table 3.1). All 
participants completed anthropometric measures (height and weight). Blood was 
drawn to assess vitamin D status (25(OH)D) and a MRI scan of the 
gastrocnemius was completed to measure gastrocnemius muscle lipid depots 
(IMCL and EMCL). Each participant completed a medical history questionnaire 
and at least one form of physical activity assessment (accelerometry, PASE or 
physical activity questionnaire). A subsample of participants completed waist 
circumference measures, DXA and CT scans, GXT, and the FSST. 
3.3.3 Statistical Analysis 
Data collected over a 4 year period from 3 different studies was combined 
and retrospectively analyzed. Power was retrospectively calculated using 
Statistical Analysis System (version 9.4, Cary, NC) to examine the relationship 
between 25(OH)D concentrations and IMCL. One participant, with a BMI of 35.2 
(obese class II category), was excluded from study analyses due to poor IMCL 
and EMCL peak separation post MRS analysis. Lack of peak separation resulted 
in an overestimation of IMCL that was 3 standard deviations (SD) above the 
mean. Based on a cross-sectional total sample of 55, a Fisher’s z-test was 
employed to retrospectively calculate a power of 75.2%. 
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Data analyses were completed using Statistical Package for Social 
Sciences software (version 22, IBM, Armonk, NY). Descriptive statistics were 
documented and Pearson correlations were employed to examine the 
relationship between continuous variables. For mean comparisons of two 
variables, the Levene’s test for equality of variance was completed following an 
independent t-test. For mean comparisons between 2 or more variables a one-
way ANOVA was employed. Linear regression was employed to investigate the 
relationship between our variables of interest. A p≤0.05 was set as statistical 
significance. Data were expressed as mean±SD. 
3.4 Results 
3.4.1 Participant Characteristics 
Participants were between 60 and 84 years of age. All participants 
completed the medical history questionnaire, blood draw, and height/weight 
measures. Total sample characteristics and sample characteristics by sex group 
are described in Table 3.2. Twenty-four participants’ were normal weight with a 
BMI range from 18.7 to 24.9kg/m2 (mean = 22.5±2kg/m2). Twenty-three 
participants were overweight with a BMI range from 25.4 to 29.9kg/m2 (mean = 
27.5±1kg/m2). Eight participants were obese (class I) with a BMI range from 30 to 
33.7kg/m2 (mean = 31.5±1kg/m2). A subsample of 42 participants completed 
waist circumference measures (mean = 90.8±13cm). Waist circumference was 
significantly different between females (n=18, 82.7±12cm) and males (n=24, 
96.8±11cm) (p<0.001).  
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3.4.2 Physical Activity and Fitness Characteristics 
Thirty-one participants completed the physical activity questionnaire. 
Participants reported their physical activity lifestyle demands as sedentary (n=1), 
slightly active (n=5), active (n=19), or very active (n=6). Twenty-four participants 
completed the GXT, PASE questionnaire, and wore an accelerometer. Due to 
non-compliance of accelerometer wear, accelerometry data were only reported 
for 23 participants. Peak VO2 measures obtained by GXT ranged from 15.5 to 
51.4mL/kg/min (mean = 30±9.3mL/kg/min) (Table 3.3). Based on previously 
established cardiovascular fitness categories [131], 5 males and 8 females were 
classified as either poor or fair and 7 males and 4 females were classified as 
either good, excellent, or superior. The PASE total score ranged from 57.2 to 
431.1 with a mean of 148.7±87.2 (Table 3.4). Participants’ time spent in light, 
moderate, and vigorous activity ranged from 666 to 940.8min/d, 23.3 to 
108.3min/d, and 0 to 8.5min/d, respectively (Table 3.5). Nineteen of the 23 
participants met the minimum 30min/d recommendation of moderate activity set 
forth by the CDC [125]. Further, vector magnitude count (counts/minute/day) was 
used as a continues variable to assess accelerometry data and ranged from 
323.2 to 884.3 (mean = 569.5±135). VO2 measures positively correlated with 
time spent in moderate activity (p=0.047) and negatively correlated with time 
spent in light activity (p=0.009). PASE questionnaire scores were not correlated 
with VO2 or accelerometry measures. 
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3.4.3 Vitamin D Status 
Nine individuals were vitamin D deficient (25(OH)D<20ng/mL) and 25 
were vitamin D insufficient (25(OH)D 20-30ng/mL). Twenty individuals were 
vitamin D sufficient (25(OH)D>30ng/mL) and 11 of 20 individuals had a 
25(OH)D>40ng/mL. 25(OH)D concentrations for normal weight participants 
ranged from 16 to 63ng/mL with a mean of 35±14ng/mL. For overweight 
participants, 25(OH)D concentrations ranged from 17 to 50ng/mL with a mean of 
29.7±8ng/mL. 25(OH)D concentrations for obese participants ranged from 15 to 
68ng/mL with a mean of 27.5±18ng/mL. Although lower mean 25(OH)D 
concentration were observed to be related with greater BMI categories, this 
relationship was not significant (Figure 3.1). BMI and waist circumference were 
correlated (p<0.001); however, 25(OH)D concentrations were negatively 
correlated with waist circumference only (p=0.03) and not BMI (Figure 3.2). 
Physical activity measured by PASE questionnaire and accelerometry did not 
correlate with 25(OH)D concentrations. Further, 25(OH)D concentrations were 
not different between reported physical activity levels (sedentary, slight active, 
active or very active).  
3.4.4 Muscle Lipid Depots Characteristics 
Mean IMCL was 0.005±0.003au with a range of 0.001au to 0.017au. Mean 
EMCL was 22.8±5.6% with a range of 8.9% to 39.8%. BMI was not correlated 
with IMCL (p=0.11) or EMCL (p=0.06). Although not significant, both muscle lipid 
depots, IMCL (Figure 3.3) and EMCL (Figure 3.4), increased with increases in 
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BMI category. Waist circumference was not correlated with either muscle lipid 
measure.  
PASE score, GXT, and accelerometry measures did not correlate with 
either muscle lipid measure. Participants that reported being active or very active 
had lower EMCL (19.4±4%) compared with those who reported being sedentary 
or slightly active (23.9±2%) (p=0.02). However, there were no significant 
differences in IMCL content between individuals of varied activity levels.  
3.4.5 Vitamin D Status, Muscle Lipid, and Physical Function  
25(OH)D concentrations were positively correlated with IMCL (p=0.008) 
(Figure 3.5). 25(OH)D concentrations were negatively correlated with EMCL 
(p=0.02) (Figure 3.6). EMCL was also significantly higher in vitamin D deficient 
individuals (25(OH)D<20ng/mL) (n=9; 26.8±6%) compared with individuals with a 
25(OH)D>40ng/mL (n=11; 20.9±3%) (p=0.009). 
Thirty-one participants completed the FSST with a mean time of 7.6±2s 
and range from 4.2 to 12.8s. In the total sample, FSST did not correlate with 
muscle lipid (Figure 3.7 (A)), 25(OH)D concentrations, BMI, or age. There were 
no observed quintile differences between the slowest (mean = 10.1±1) and 
fastest (mean = 5.5±1s) times to complete the FSST. There were significant 
differences in FSST between males (n=15, mean 6.9±2s) and females (n=16, 
mean 8.3±2s) (p=0.05). 
 In males no significant relationship was observed between 25(OH)D 
concentrations, FSST (Figure 3.7 (B)), and muscle lipid. Conversely, females 
with greater 25(OH)D concentrations had faster FSST times (p=0.007) (Figure 
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3.7 (C)). In females, FSST positively correlated with BMI (p=0.012). Although no 
correlation between FSST and muscle lipid depots were observed, 25(OH)D 
concentrations (p=0.004) and EMCL (p=0.013) were significant predictors of 
FSST when adjusting for BMI (p=0.558) and age (p=0.163) in the model (Table 
3.6). 
3.4.6 Muscle Lipid, Vitamin D Status, and Body Composition 
IMCL and EMCL did not correlate with DXA or CT measures in the 
subsample that completed body composition measures. Higher 25(OH)D 
concentrations correlated negatively with total lean, leg, arms, trunk, android, and 
gynoid (p≤0.005). 25(OH)D concentrations were not associated with any fat 
measures.  
3.5 Discussion 
The purpose of this retrospective study was to examine the relationship 
between 25(OH)D concentrations, muscle lipid depots, and physical function. 
Our primary findings were that 25(OH)D concentrations were negatively 
associated with EMCL and were not associated with IMCL when outliers, defined 
as IMCL data points that was 1.5 times greater than the interquartile range, were 
removed. 25(OH)D concentrations were related with physical function. In females 
only, 25(OH)D concentrations and EMCL were the best predictors of faster 
FSST. We assessed muscle lipid depots and 25(OH)D concentrations between 
different BMI categories and physical activity levels. With higher BMI categories, 
decreases in 25(OH)D concentrations and increases in muscle lipid depots were 
observed, but statistical significance was not reached. There were no significant 
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differences in muscle lipid depots with varied physical activity levels. Together 
these data suggest that vitamin D status and muscle lipid depots play a role in 
physical function and support previous study findings [55, 86].  
In accordance with previous literature, we observed a negative linear 
association between EMCL and 25(OH)D concentrations [55, 86]. Although the 
metabolic role of EMCL remains largely unknown, higher EMCL has been 
associated with decreased physical function and increased insulin resistance [58, 
74]. Gilsanz et al. [86] observed a negative relationship between 25(OH)D 
concentrations and fat infiltration in 90 postpubertal, healthy females (16-22YO). 
Women with 25(OH)D≤29ng/mL had 24% greater muscle fat infiltration than 
women with 25(OH)D≥30ng/mL. We observed that those with lower 
(25(OH)D≤20ng /mL) has 6% greater EMCL compared with those with higher 
(25(OH)D≥40ng/mL) vitamin D status. Although both our studies and Gilsanz et 
al observed significant differences in EMCL content the magnitude of EMCL 
varied. This variation of EMCL content between high and low vitamin D status 
can be attributed to multiple factors including different subject characteristics, 
sample size, and different techniques used to assess EMCL and physical 
function. As no gold standard for quantifying EMCL exists, it can be difficult to 
compare results across studies. We manually highlighted regions of interest and 
quantified fat content in the gastrocnemius using a previously published formula 
[103]; whereas others used CT [86] or MRI and subjectively graded images [55]. 
Tagliafico et al. [55] observed a similar relationship between 25(OH)D 
concentrations and fat infiltration in 65 year old patients that were admitted to an 
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internal medicine ward for non-oncological diseases. The authors reported that 
individuals with lower 25(OH)D concentrations and greater fat infiltration had 
impaired balance and gait. We did not observe a relationship between EMCL and 
our physical function measure, FSST. However, in females higher, 25(OH)D 
concentrations and lower EMCL content were significant predictors of FSST 
performance times when adjusting for age and BMI. This was not observed in 
male participants potential due to the wider distribution of 25(OH)D 
concentrations in females compared with males. The majority (87%) of males 
were vitamin D insufficient, whereas 25(OH)D concentrations were normally 
distributed in females. These data indicate that there may be a relationship 
between vitamin D, EMCL, and physical function as previous studies have noted.  
The metabolic role of IMCL has been investigated for over two decades. 
High IMCL content with physical inactivity has been associated with greater 
insulin resistance [77]. Paradoxically, active individuals also exhibit high IMCL 
content, but these relationships have been linked to greater insulin sensitivity. 
Previously, our lab observed a positive linear relationship between 25(OH)D and 
IMCL in healthy older adults independent of physical activity and BMI [59]. In this 
retrospective analysis a significant relationship between 25(OH)D and IMCL was 
observed; however this significant relationship may not be a true finding as three 
data points drove this correlation to significance. Further, the discrepancy 
between our current and past findings may be due to multiple other factors. With 
a retrospective analysis a sample size of 55 provided us with a power of 75%, 
thus we may be underpowered to detect significance between IMCL and 
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25(OH)D concentrations. In addition, the majority of our sample (62%) had a 
25(OH)D≤30ng/mL, while only 20% of our sample had a 25(OH)D>40ng/mL. The 
narrow distribution in the 25(OH)D concentrations may have further contributed 
to our lack of findings between vitamin D status and IMCL.  
Multiple methods were used to assess physical activity and no participant 
enrolled partook in an aerobic or resistance training regimen prior to start of the 
study. Compared to physical activity, which encompasses routine daily activities, 
exercise differs as it is defined as a planned, structured and repetitive task. [93]. 
Previous trials have observed that short and long term exercise influence muscle 
lipid depots and positively affected muscle health [74, 94, 95]. In our study, we 
aimed to examine the relationship between muscle lipid depots and physical 
activity. We did not observe any relationship between muscle lipid depots and 
physical activity measures (PASE questionnaire, accelerometry wear, or GXT). 
However, as measured by the physical activity questionnaire, significantly lower 
EMCL content was observed in individuals who reported being more active to 
those individuals who reported being less active. Greater EMCL has been 
associated with decreased gait and stability in older adults and engaging in an 
exercise program has been shown to reduce EMCL [55, 74]. Our findings were 
novel as the data suggests that increased physical activity and not just 
engagement in an exercise regimen were related with lower EMCL content. 
Unlike our physically active participants of which 83% met the CDC requirements 
[125], less than 5% of general adult population engages in 30min/d of physical 
activity [138]. Greater physical activity can delay or help maintain quality of life 
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and provide an independent lifestyle with aging. Therefore, physical activity 
should continue to be emphasized and encouraged in community and clinical 
settings.  
In addition to physical activity, lower adiposity can play an important role in 
overall health. It is well established that even during periods of stable body 
weight, lipid deposition changes occur with aging [90]. Central obesity increases 
and fat infiltrates various tissues including the skeletal muscle. We did not detect 
significant differences between BMI categories and muscle lipid depots, which 
may be due to a small obese category sample size. de La Maza et al. [79] 
observed increased muscle lipid depots (EMCL and IMCL) in both young (27-
55YO) and older (66-80YO) men. In the total sample, the authors observed that 
overweight men had higher IMCL and EMCL compared with normal weight men. 
Further, a significant positive relationship between muscle lipid depots and both 
abdominal and trunk fat accumulation was observed. These data suggests that 
independent of age, central obesity plays a major role in muscle lipid depots 
accumulation. In our total sample, we did not observe a significant difference in 
muscle lipid depots between BMI categories or central adiposity measures. 
However, a general increase in muscle lipid depots was observed with increases 
in BMI category. To decrease confounding variables we further examined these 
results between females and males and observed that obese males had greater 
IMCL content compared with normal weight males. This relationship was not 
observed in females, which may be due the small sample size of only 3 females 
classified as obese. Therefore, the discrepancy in significance can be attributed 
93 
to the strict study selection. To avoid confounding variables de la Maza et al. [79] 
recruited only young and older men with comparable body weights and physical 
activity levels.  
Velan et al. [84] observed that with greater BMI categories (normal weight, 
overweight, and obese) younger men had increased IMCL and EMCL content. 
Study selection was limited to healthy males not involved in any high-level 
exercise training. With a small sample size of only eight individuals per group, 
Velan et al. [84] detected significant differences in muscle lipid depots between 
BMI categories. The discrepancies between Velan et al. [84] and our findings 
could be that muscle lipid depots differences between BMI categories were more 
difficult to detect due to the confounding variables of age and physical activity. 
With age, changes in adiposity occur even during periods of weight stability [90] 
and our study included a 24-year range between our youngest and oldest 
participant. Further, in our study a wide distribution of physical activity was 
documented. For example, 9 of 22 participants exceeding the CDC 
recommendations of 30min/d [125] and engaged in more than 1 hour of 
moderate physical activity. Despite the lack of significance, which in part can be 
contributed to our heterogeneous sample, our results were in alignment with 
previous literature as muscle lipid depots increases were observed with 
increases in BMI categories.  
Increases in adiposity have also been associated with decreased vitamin 
D status. Two hypotheses have been attributed to the aforementioned 
association, the fat sequestration hypothesis [42] in which the lipophilic nature of 
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vitamin D promotes significant storage in adipose tissue and the volumetric 
dilution hypothesis, [41] which suggest that the greater body size and fat mass 
were associated with lower 25(OH)D concentrations. In our study we observed a 
lower mean 25(OH)D concentration with greater BMI categories. Compared to 
normal weight individuals, previous studies have observed a greater vitamin D 
deficiency prevalence among obese individuals [43] while also showing small but 
significant increase in 25(OH)D concentrations with weight loss [39]. We 
observed a general mean decrease in 25(OH)D concentrations with increases in 
BMI category and a significant negative relationship between waist 
circumference and 25(OH)D concentrations. Waist circumference can be a more 
sensitive measure of central adiposity than BMI, as with BMI normal weight, 
overweight, and obese individuals can have comparable fat mass but fat may be 
distributed in different parts of the body [139, 140]. We used more sophisticated 
measures to assess adiposity (DXA and CT scans) and did not observe any 
relationship with 25(OH)D concentrations and adiposity; however, these 
measures were only completed in a subsample of participants (n=18) of which 9 
were normal weight, 6 were overweight, and 3 were obese. Our data provides 
further evidence for decreased 25(OH)D concentrations with greater central 
adiposity. 
There are limitations to this specific aim, primarily due to the nature of a 
retrospective study design. Data was combined from 3 cross-sectional trials and 
participants were recruited over a 4 year period and completed varied study 
measures. Despite this, the inclusion and exclusion criteria was similar across 
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each trial and primary variables of interest (muscle lipid depots and vitamin D 
status) were measured using the same methodology. We observed that higher 
25(OH)D concentrations and lower EMCL content were the best predictors of 
physical performance. Further, a novel finding was that higher physical activity 
levels were related with lower EMCL content. Future intervention trials are 
necessary to determine if vitamin D supplementation in vitamin D deficient adults 
can result in decrease in EMCL, effect IMCL, and improve overall physical 
function.  
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Table 3.1 Study trials and measures completed 
Trials 
1 2 3 
(n=13) (n=18) (n=24) 
Active Study Year 2012 2012-2013 2014-2016 
Study Measures  
Muscle Lipid Depots x x x 
Blood Draw x x x 
Height/Weight x x x 
Waist Circumference x x 
Physical Activity 
Questionnaire x x  
PASE Questionnaire x 
Accelerometery  x 
GXT     x 
DXA  x  
CT   x   
FSST x x   
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Table 3.1 Study trials and measures completed 
 A list of measurements obtained, sample sizes, and the year each cross-
sectional trial was completed.   
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Table 3.2 Subject characteristics, mean±SD 
 Female  
(n=28) 
Male 
(n=27) 
Total 
(n=55) 
Age (years) 71±6 70.6±6 70.8±6 
Height (cm) 163±7* 176.4±5* 169.6±9 
Weight (kg) 66.3±10* 84±12* 75±14 
Body Mass Index (kg/m2) 25±4* 27±3* 25.9±4 
25(OH)D (ng/mL) 35.3±13* 28±11* 31.7±13 
Race (n)    
White 32 22 54 
African American 0 1 1 
*Significant differences between females and males (p<0.05) 
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Table 3.3 VO2 peak measures between males and females across age 
categories 
Age (yr) Females 
(n=12) 
Males  
(n=12) 
Total  
(n=24) 
60-69 25.7±8 
(n=7) 
34.8±10 
(n=9) 
30.8±10 
(n=16) 
70-79 23.8±7* 
(n=5) 
36±4*  
(n=3) 
28.4±9 
(n=8) 
*Significant differences between females and males (p<0.05) 
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Table. 3.3 Peak VO2 measures between males and females across age 
categories 
Categories used were based on previous guidelines by Heyward et al. 
[131] No differences in peak VO2 within sex categories and across age groups 
was observed. Males and females in each age category were statistically 
different between sexes with females reaching a lower peak VO2 levels.  
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Table 3.4 PASE questionnaire by age category, mean±SD 
 60-64 YO  
(n=8) 
65-69 YO 
(n=8) 
70-75 YO 
(n=6) 
76-100 YO 
(n=2) 
Total  
(n=24) 
Males 
 
116.9±58 
(n=5) 
124.1±32  
(n=4) 
140.3±41 
(n=3) 
 
(n=0) 
125.2±43 
(n=12) 
Females 
 
199.4±201 
(n=3) 
225.7±85 
(n=4) 
119.3±42  
(n=3) 
104.3±44 
(n=2) 
172.3±113 
(n=12) 
No statistical differences 
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Table 3.4 PASE questionnaire by age category, mean±SD 
Age categories were based on the New England Research Institutes’ 
PASE questionnaire. No statistical differences in PASE score between males 
and females within or across age groups were observed.  
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Table 3.5 Minutes per day spent in each activity level, mean±SD 
 Female  
(n=11) 
Male 
(n=12) 
Total 
(n=23) 
Light Activity   
(<3METS) 
837.6±62* 785.5±59* 810.4±65 
Moderate Activity  
(3-6 METS) 
49.5±22 66.7±25 58.5±25 
Vigorous Activity 
(>6 METS)  
0.2±0.2 0.9±2 0.6±2 
*Significant differences between females and males (p<0.05) 
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Table 3.5 Minutes per day spent in each activity level, mean±SD 
Time (minutes) spent per day in light, moderate, and vigorous activity 
levels. Females significantly spent more time in sedentary activity category 
compared with males.  
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Figure 3.1 25(OH)D concentrations across BMI categories 
25(OH)D concentrations were reported across 3 BMI categories (normal 
weight, overweight, and obese (A)) and across 2 BMI categories (normal weight 
vs. overweight+obese (B)). Although a decrease in 25(OH)D from normal weight 
to obese was observed mean 25(OH)D was not significantly different between 
BMI categories. 
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Figure 3.2 The relationship between 25(OH)D and waist circumference  
Waist circumference and 25(OH)D measures included males and females. 
25(OH)D was negatively correlated with waist circumference. 
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Figure 3.3 IMCL across BMI categories 
IMCL contents were reported across 3 BMI categories (normal weight, 
overweight, and obese (A)) and across 2 BMI categories (normal weight vs. 
overweight+obese (B)). Although an increase in IMCL from normal weight to 
obese was observed, the mean IMCL was not significantly different between BMI 
categories.  
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Figure 3.4 EMCL across BMI categories 
EMCL contents were reported across 3 BMI categories (normal weight, 
overweight, and obese (A)) and across 2 BMI categories (normal weight vs. 
overweight+obese (B)). Although an increase in EMCL from normal weight to 
obese was observed, mean EMCL was not significantly different between BMI 
categories.  
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Figure 3.5 Relationship between 25(OH)D and IMCL   
A significant positive linear relationship was observed between 25(OH)D 
and IMCL (A). IMCL data distribution depicted in a boxplot (B).  
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Figure 3.6 Relationship between 25(OH)D and EMCL 
A significant negative linear relationship was observed between 25(OH)D 
and EMCL (A). The relationship remains significant despite the one data point 
that was 1.5 times greater than the interquartile range (B).   
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Figure 3.7 The relationship between 25(OH)D and FSST 
The scatter plots indicate a negative relationship between greater 
25(OH)D concentrations and improved physical function, as measured by the 
faster FSST times, in the total sample (A), males (B), and females (C). A greater 
25(OH)D concentration was significantly related with faster FSST times in 
females only.   
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Table 3.6 Variables that predict FSST 
Predictor Variable  
Estimate 
(Standardized 
Coefficients (Beta)) 
p-value 
25(OH)D  -0.616 0.004 
EMCL  0.585 0.013 
BMI 0.116 0.558 
Age -0.271 0.163 
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Table 3.6 Variables that predict FSST 
 BMI and age were not significant predictors of the FSST. Greater vitamin 
D levels were a significant predictor of lower time to complete the FSST. Greater 
EMCL content was a significant predictor of greater time to complete the FSST.  
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Chapter 4: Specific Aim 2 
4.1 Summary 
Dietary fat intake, physical activity, and body mass index (BMI) may play a 
role in age-associated changes in muscle lipid depots and local muscle tissue. 
Higher intake of saturated fatty acids (SFA) was associated with greater 
intramyocellular lipid (IMCL) content and lower lipid turnover in animal models. 
Conversely, high intake of polyunsaturated fatty acids (PUFA) and 
monounsaturated fatty acids (MUFA) were associated with increased lipid 
turnover and improved metabolic health. In addition to diet, exercise plays an 
important role in maintaining muscle health. However, to date human data 
examining the relationship between modifiable lifestyle factors, diet and physical 
activity, and muscle lipid depots are not well established. PURPOSE: The 
purpose of this retrospective trial was to examine how dietary fat intake and 
physical activity contribute to muscle lipid depots (IMCL and extramyocellular 
lipid (EMCL)) and local muscle tissue hemodynamics in healthy, aged 
individuals. METHODS: All participants were enrolled in a double-blinded 
randomized-controlled trial (four group design: vitamin D repletion or placebo for 
12wks with an additional week of aerobic training or no training). Twenty-four 
hour dietary recalls were completed to assess dietary fat intake. Physical activity 
questionnaire and graded exercise test (GXT) were completed at baseline (0wks) 
and accelerometry wear was completed at baseline, midpoint (7wks), and 
endpoint (13wks). Gastrocnemius IMCL and EMCL were measured with 
magnetic resonance spectroscopy (MRS) and fat segmentation at baseline and 
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endpoint near-infrared spectroscopy/diffuse correlation spectroscopy 
(NIRS/DCS) measures were obtained before, during, and after a foot plantar 
flexion exercise at 0 and 13wks. RESULTS: Twenty-four participants completed 
all study measures. Mean age and BMI were 67.2±5YO and 25.3±4kg/m2, 
respectively. EMCL was positively associated with SFA intake (p=0.026). EMCL 
was greater in overweight and obese individuals compared with normal weight 
individuals (p=0.006) and BMI was the only significant predictor of EMCL. 
PUFA:SFA ratio was negatively related with IMCL at endpoint (p=0.029). With a 
stepwise linear regression employed, the aerobic training protocol (p=0.014) and 
the PUFA:SFA ratio (p=0.037) were the best predictors of IMCL when adjusting 
for BMI, age, and time spent in moderate physical activity. Individuals that 
reported greater physical activity exhibited lower relative blood flow (rBF) and 
relative oxygen consumption rate (rVO2) during and after a plantar flexion 
exercise. CONCLUSION: In concomitant with previous literature, these data 
suggest that a higher unsaturated to SFA ratio intake may have a favorable effect 
on muscle lipid depots and lipid turnover. Although preliminary in nature, 
increased daily physical activity could relate with local muscle tissue 
hemodynamics.    
4.2 Introduction 
Muscle composition alterations are observed with aging including 
decreases in lean mass and increases in fat accumulation [30, 56, 77]. Inactivity 
often increases with aging, further contributing to reduced muscle strength and 
function [125]. In order to mitigate the deleterious muscle changes, it is 
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imperative to understand the role of modifiable lifestyle factors on skeletal 
muscle. Modifiable lifestyle factors can effect muscle lipid depots (IMCL and 
EMCL) and local muscle tissue hemodynamics, which have been implicated in 
muscle health [30, 100, 141]. In older adults, EMCL accumulation has been 
associated with increased muscle weakness and decreased mobility [30, 55]. 
Conversely, high IMCL in combination with high lipid turnover has been 
associated with insulin sensitivity [77, 141]. With aging, decreases in capillary 
density were responsible for local tissue hemodynamics changes [142, 143]. 
Concurrently, lower erythrocyte perfusion is observed because of increased 
thickness and impairments in the endothelial layer [142, 143]. Modifiable lifestyle 
factors including exercise and dietary intake may positively alter muscle lipid 
depots and skeletal muscle hemodynamics. 
In both animals and humans, dietary interventions effect muscle lipid 
depots, IMCL and EMCL. The type of fat (SFA or unsaturated fatty acids) 
consumed may be an important factor in lipid metabolism. Kakehi et al. [87] 
observed that a 3d high fat diet (HFD) intervention, primarily composed of SFA, 
led to an increase in IMCL accumulation and impaired insulin sensitivity. St-Onge 
et al. [90] observed higher IMCL content with 2 different HF diets (PUFA-rich and 
SFA-rich) compared with a low fat diet; however, the authors noted that the 
metabolic significance of a lower or higher IMCL content was unclear. In animal 
models, a high PUFA diet intervention had a protective effect against the 
development of insulin resistance [88]. A PUFA-rich diet was also associated 
with greater IMCL turnover and lower muscle fatty acid uptake. It is thought that, 
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due to the chemical structures, unsaturated fatty acids were more readily 
oxidized compared with SFA [88, 89]. Greater lipid oxidation is associated with 
increased lipid turnover, which may prevent the build-up of deleterious lipid 
metabolites and promote insulin signal transduction leading to improved insulin 
sensitivity [88]. Increased EMCL has been consistently associated with insulin 
resistance and obesity [30, 144]. Overall decrease in caloric intake and weight 
loss have been shown to decrease EMCL content [30]. After combined 7 
consecutive day aerobic training and a low glycemic index dietary intervention, 
Haus et al. [74] observed decreases in EMCL and increases in IMCL. These 
muscle lipid depots changes were associated with improved insulin sensitivity 
and were only attributed to the exercise regimen intervention. As weight loss is 
accompanied by muscle mass loss, weight loss alone may not be a desirable 
option for older adults. Therefore, increased physical activity levels and modified 
dietary fat intake, rich in unsaturated fatty acids, may be one way to mitigate age-
associated muscle lipid depots accumulation.  
Similar to dietary intake, physical activity is a modifiable lifestyle factor that 
influences muscle function. Physical activity differs from exercise as it is 
considered to as activities of daily living; whereas exercise is defined as a 
structure, planned and repetitive activity [93]. Inactivity increases with age, with 
33% of men and 50% of women 75 years of age or older, reporting no 
engagement in physical activity [125]. Physical activity contributes to aerobic 
fitness which decreases with aging. Aerobic fitness can be assessed with global 
body VO2 measures [131]. Global oxygen consumption is the measure of total 
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volume of oxygen consumed by the body per minute [145]; however, global 
oxygen measures fail to monitor and assess the delivery of nutrients to the 
tissues [104]. NIRS/DCS hybrid techniques allow us to examine skeletal muscle 
hemodynamic changes during exercise and to further understand how the 
muscle adapts during times of stress. In older adults the greatest improvement in 
global VO2max was observed in aerobic training programs that were more than 
20 weeks in duration with training intensities of 60-70% of VO2max [146]. With 
aging, impairments of local microvascular oxygen delivery and exchange in 
human skeletal muscle occur [142]. DeLorey et al. [147] observed that adaption 
of regional muscle oxygen delivery was slower in older adults compared to 
younger adults at the onset of a moderate-intensity exercise. In younger trained 
adults a faster re-oxygenation (VO2 recovery time) of the muscle following an 
exercise was observed compared with untrained adults [148]. Further, exercise 
training in heart failure patients has been show to improve local muscle tissue 
oxygenation [148]. However, as inactivity increases with aging it is important to 
assess the relationship between physical activity levels, not exercise, and local 
muscle tissue hemodynamics during increased energy demands.     
Our retrospectively analysis was part of a double-blinded randomized-
controlled trial, in which participants were enrolled into 1 of 4 groups: a combined 
treatment of vitamin D repletion and aerobic training, vitamin D repletion alone, 
aerobic training alone, or control conditions. In this trial we examined the 
relationship between dietary fat intake and muscle lipid depots (IMCL and 
EMCL). In addition, our objective was to determine the relationship between 
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global VO2, physical activity levels, and local muscle tissue hemodynamics in 
individuals 60 years of age or older.  
4.3 Methods 
4.3.1 Participants 
Retrospective analyses were based on participants enrolled in the double-
blinded randomized, placebo-controlled trial. Both females and males, 60 years 
of age or older, were recruited through word of mouth and local advertisements. 
Exclusion criteria included history of myopathy and rhabdomyolysis, uncontrolled 
hypertension, positive smoking status, inflammatory bowel disease, diabetes, 
primary hyperparathyroidism, renal disease, or a measured BMI of <18.5 or 
>34kg/m2. In addition, individuals with lower extremity injury or surgery 3 months 
prior to study enrollment were excluded. Participants with a vitamin D (25(OH)D) 
status of ≤32ng/mL and asymptomatic findings from the GXT were enrolled and 
randomized to one of four study arms. The institutional review board approved 
the study and written consent was obtained prior to study measures. 
4.3.2 Study Design 
Participants 60 years or older with vitamin D insufficiency (25(OH)D 
<32ng/mL) were randomized to a 13 week double-blinded, four group design 
intervention. Vitamin D3 (10,000IU x 5d/wk) or placebo was provided for 12 
consecutive weeks. After the initial 12wk period, one additional week (7 
consecutive days) with or without aerobic training was completed by both the 
placebo and vitamin D supplementation groups (Figure 4.1). Screening visits 
consisted of a blood draw to assess vitamin D status and a GXT to assess for 
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any contraindication to study enrollment. Baseline measures (week 0) consisted 
of anthropometry (height, weight, waist circumference) and PASE questionnaire. 
At baseline and endpoint (week 13) participants completed MRI to assess 
muscle lipid depots and NIRS/DCS measures during a foot plantar flexion 
exercise to assess gastrocnemius’ hemodynamics. Accelerometry wear and 
dietary recalls were completed at baseline, midpoint (week 7) and endpoint.  
4.3.3 Statistical Analysis 
Data were analyzed using IBM’s Statistical Package for the Social 
Sciences (SPSS, version 22.0) and included descriptive statistics, independent t-
test, analysis of variance (ANOVA), repeated measures analysis of variance 
(RMANOVA), Person correlations, and linear regression. Independent t-test was 
used to compare differences between participant characteristics. A RMANOVA 
was employed to examine differences in dietary intake, physical activity levels, 
and muscle lipid depots over time. Pearson correlation was used to assess the 
relationship between 2 continuous variables. Stepwise linear regression was 
employed to investigate the predictors of IMCL. Mean and SD were reported as 
mean±SD and statistical significance was defined as p≤0.05.   
4.4 Results 
4.4.1 Participant Characteristics  
This retrospective study included a total of 24 adults between the ages of 
60 and 79. Baseline subject characteristics, age, BMI, and waist circumference 
are described in Table 4.1. Participants’ educational attainment ranged from a 
General Education Development (GED) to a doctoral degree and income range 
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was between $11,500 and $210,000. BMI, weight, and waist circumference did 
not significantly differ from baseline to endpoint in the total sample or among sex 
groups.   
4.4.2 Muscle Lipid Depots Characteristics 
IMCL and EMCL measures over time (baseline to endpoint) were not 
statistically different (Table 4.2). IMCL was positively correlated with age 
(p=0.009) (Figure 4.2). IMCL did not differ between normal weight individuals and 
those with a BMI>25kg/m2 at baseline. When compared with normal weight 
individuals, EMCL was greater in individuals with a BMI≥25kg/m2 at baseline 
(p=0.006) (Figure 4.3 (A)). At baseline, EMCL was positively correlated with BMI 
(p=0.001) (Figure 4.3 (B)) and waist circumference (p<0.035) (Figure 4.3 (C)). 
Baseline BMI was the best predictor of EMCL (p=0.002) independent of age or 
time spent in moderate physical activity (Table 4.3). IMCL and EMCL were not 
different between the 4 study groups at baseline.   
4.4.3 Dietary Intake and Muscle Lipid Depots 
Dietary intake including total energy (kcal), fat (g), carbohydrate (g), 
protein (g) were not different between the 3 study time points (baseline, midpoint, 
and endpoint) or by study groups. Total and percent energy, fat, and 
carbohydrate intake are described in Table 4.4. Total and percent dietary fat 
intake is described in Table 4.5. Males had a greater intake of total SFA 
(p=0.008), PUFA (p=0.009), and MUFA (p=0.02) compared with females (Table 
4.5). However, there were no differences in percent intake of dietary fats 
between sexes. EMCL at baseline was positively correlated with percent calories 
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from fat, which can be primarily attributed to SFA, as SFA was the only dietary 
variable positively associated with EMCL (Figure 4.5). Although SFA was 
positively correlated with EMCL, BMI remained the best predictor of EMCL 
(Table 4.6). 
PUFA to SFA ratio negatively correlated with endpoint IMCL (p=0.029). 
IMCL content decreased in individuals that consumed a higher PUFA relative to 
SFA diet (Figure 4.6). Endpoint 25(OH)D concentrations were not associated 
with endpoint IMCL measures. A stepwise linear regression was employed 
indicating that aerobic training and PUFA:SFA ratio were the only significant 
predictors of IMCL (Table 4.6).  
4.4.4 Physical Activity and Local Muscle Tissue Hemodynamics 
During NIRS/DCS measures one participant was not compliant with 
procedures because the participants continuously moved their leg throughout 
testing and completed less than 30 seconds of the 3 minute arterial occlusion 
protocol. Due to lack of compliance, the participant’s data was 1.5 times greater 
than the interquartile range, and thus the participant was removed from 
NIRS/DCS analysis. We observed no correlation between hemodynamic 
measures and subject characteristics, age and BMI. There were no NIRS/DCS 
measurement differences between males and females. Neither time spent in 
moderate activity nor total activity were related with local tissue hemodynamics. 
Further global of aerobic capacity, as measured during GXT, did not correlate 
with local muscle tissue hemodynamics. PASE questionnaire scores were 
negatively correlated with rVO2 during plantar flexion (p=0.048), 1 minute after 
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(p=0.05), and at full recovery (p=0.05) (Figure 4.7 A-C). A lower rBF was also 
observed with greater PASE scores 1 minute after plantar flexion exercise 
(p=0.059) and at full recovery (p=0.083).  
4.5 Discussion 
The aim of the study was to examine the relationship between dietary fat 
intake and muscle lipid depots (IMCL and EMCL). In addition, we examined the 
relationship between aerobic capacity, physical activity levels, and local muscle 
tissue hemodynamics in healthy older adults enrolled in a randomized controlled 
trial. Our primary finding was that a greater dietary SFA intake was positively 
correlated with EMCL and a healthier dietary fat intake ratio (PUFA:SFA) was 
negatively correlated with IMCL. Past studies examined the effects of short- and 
long-term dietary interventions on muscle lipid depots. The novelty of this study 
was that we examined the relationship between muscle lipid depots and daily 
eating habits in a generally healthy older cohort. Further, in individuals that 
reported higher activity levels, we observed lower gastrocnemius rBF and rVO2 
during and after a plantar flexion exercise. These data suggest that a higher 
PUFA:SFA diet is related with lower IMCL and potentially greater physical activity 
levels may relate with local tissue hemodynamics.  
 We provide further evidence for age-associated increases in IMCL 
content. Crane et al. [149] observed that older adults had higher IMCL content 
and greater lipid droplet size along with a reduced number of muscle 
mitochondria. Haus et al. [74] observed that older insulin resistant obese men 
that engaged in a short exercise intervention (7 consecutive day of aerobic 
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training) had increased IMCL and improved insulin sensitivity; however, 
mitochondrial changes were not investigated. In addition to increased IMCL 
content, improved mitochondrial oxidative capacity was seen in older adults 
engaged in a longer (16wk) exercise regimen [77]. As a result of exercise 
training, higher IMCL content was associated with insulin sensitivity [77]. 
Therefore, the importance of IMCL content is closely linked to the mitochondria’s 
ability to metabolize lipid when needed, such as in time of exercise.  
 Both physical activity and dietary intake are modifiable lifestyle factors that 
play a vital role in muscle health. Our participants’ dietary habits met the 
Recommended Dietary Allowance (RDA) for percent caloric intake of 
carbohydrate (45-65%), fat (20-35%), and protein (10-35%) [150]. On average, 
females met the recommendations for SFA intake (≤10% from total calories), 
while males consumed slightly more than the recommended amount (12%). 
There are no current recommendations for unsaturated fatty acid intake, but it is 
widely accepted that to reduce the risk of diseases, such as cardiovascular 
disease or diabetes, reducing SFA to <10% of calories per day and replacing 
SFA with unsaturated fatty acids is necessary [151]. 
 Adipose tissue is the primary site of storage for excess caloric intake [30, 
88]. During aging, a redistribution of fat depots occurs even if total body fat is 
maintained [90]. Characteristically with aging, fat infiltrates various tissues such 
skeletal muscle as fat storage sites change from the less deleterious 
subcutaneous fat to visceral fat [30]. We observed a positive correlation between 
increased SFA intake and EMCL. Although we observed that a higher dietary fat 
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intake was related with increased EMCL, BMI remained the best predictor of 
EMCL. In combination with previous data, our findings further support that 
greater BMI is the major contributor to increased EMCL and that an overall 
healthy lifestyle is necessary to maintain muscle health. Future studies should 
focus to examine if weight loss can reduce EMCL. 
We also observed that PUFA:SFA ratio intake was negatively correlated 
with IMCL content. Since our findings were observed at endpoint we further 
examine if the diet fat ratio or the study intervention was the best predictor of this 
relationship. We observed that the best predictors of IMCL were both PUFA:SFA 
ratio and aerobic training. Although our retrospective analysis was not able to 
assess lipid turnover or mitochondrial oxidation, previous studies have shown 
that a higher unsaturated fatty acid diet and exercise led to lower dietary fat 
uptake by the muscle [84, 88, 89]. Jans et al. [89] suggested that these 
observations may be due to the chylomicrons rich in PUFA and MUFA that were 
more readily removed from the circulation by hepatic lipase instead of lipoprotein 
lipase. The authors suggest that post-PUFA meal an improvement in 
postprandial insulin sensitivity occurs compared with SFA, which would 
decreases fatty acid uptake by the muscle. Lower muscle lipid uptake 
accompanied by greater removal of the chylomicrons from the circulation would 
potentially lead to a reduction in muscle fat accumulation and an increase in 
muscle lipid turnover. Further, animal studies suggest that the type of fatty acids 
consumed exert influence on the processing of the lipids during beta-oxidation. 
Due to their chemical structure, unsaturated fatty acids seem to be preferentially 
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oxidized over SFA [88]. Unsaturated fatty acids contain one or more double 
bonds, whereas SFA do not contain double bonds. Double bonds are more 
reactive and easily susceptible to modifications. These chemical structural 
differences lead to unsaturated fatty acids’ preferential oxidation, which in turn 
may lead to greater muscle lipid turnover and overall improved muscle health. 
This was further seen in normal weight individuals who had a greater degree of 
unsaturation compared with those in a higher BMI category [84]. Synthesis of 
unsaturated fatty acids through desaturation of SFA was decreased in 
overweight and obese individuals. The reduced degree of unsaturation in 
overweight and obese individuals may be involved in increased lipid peroxidation 
and damage to the myocytes. Combining our retrospective findings with previous 
studies, these data suggest that maintaining a healthy diet, in particular partially 
replacing SFA with healthier fats (PUFAs and MUFAs), may play a beneficial role 
in muscle health.  
Higher levels of physical activity are important to preserve muscle health 
and function. We examined the relationship between gastrocnemius 
hemodynamics during a foot plantar flexion exercise with physical activity levels 
measured by accelerometry and PASE questionnaire and global oxygen 
consumption measured during a GXT. Although participants moderate physical 
activity levels, measured by accelerometry wear, ranged from 20min/d to 
108min/d, the majority (82%) of the participants met the CDC’s guideline for 
moderate physical activity [125]. Further, accelerometry vector magnitude 
counts, a continues variable was examined, but was not related with local muscle 
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tissue metabolism. The lack of variance in physical activity could have precluded 
our ability to detect a relationship between low and high moderate physical 
activity levels and local muscle tissue hemodynamics.  
In addition, we examined the relationship between peak VO2, measured 
by GXT, and local tissue hemodynamics. Peak VO2 measures provide 
information about cardiovascular health and in our sample we had a large 
distribution (15-50mL/kg/min), of which 45.8% of participants had poor to fair 
cardiovascular fitness. Global oxygen consumption impairments are not always 
apparent and the need to examine microvascular changes is necessary because 
it can provide more nuanced assessment of physiological changes associated 
with aging [152]. Marengi et al. [153] observed that younger adults a tight 
correlation between global and local VO2 exists. The authors simultaneously 
measured local VO2 of the vastus lateralis and global VO2 during a graded cycle 
ergometry test performed until volitional fatigue. The discrepancy between our 
findings may be attributed to multiple factors. We did not complete global and 
local VO2 measures simultaneously. Our global VO2 measures taken during a 
graded treadmill exercise test and local gastrocnemius VO2 measures were 
completed during a plantar flexion exercise. Participants were also instructed to 
continue the GXT until volitional fatigue, but the foot plantar flexion protocol was 
set to 75 repetitions, in which participants may not have reached exhaustion. 
Therefore, it was not surprising that we did not observe a relationship between 
peak VO2 and local VO2 as measured by NIRS/DCS.   
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Based on PASE questionnaire findings, we observed that individuals that 
reported engaging in more physical activity had lower rVO2 during, immediately 
after, and at full recovery of the foot plantar flexion exercise. In individuals that 
were more active, muscles may be more adapt to increases in demand; 
therefore, during periods of stress the relative increase in BF and VO2 was lower 
during and after exercise compared with less active individuals. We observed 
that physical activity was the best predictor of rVO2 independent of BMI and age. 
Although the significance of our findings was that greater physical activity levels 
in older adults may be helpful in preventing microvascular dysfunction that occurs 
with aging, these results should be interpreted conservatively.  
There are multiple limitations to our findings. First, only PASE 
questionnaire was correlated with local muscle tissue oxygen consumption and 
blood flow. The PASE questionnaire is a reliable and valid assessment of 
physical activity in older adults; however accelerometry is a better measure. As 
accelerometry data did not correlate with local muscle tissue metabolism the 
relationship between physical activity and local muscle tissue still remains 
unclear. Future studies should aim to further the understand of how physical 
activity, not exercise, may contribute to local muscle oxygen use and impact 
overall heath. Our findings show a relationship between aerobic training, 
favorable dietary fat intake and lower IMCL. However, the impact of these 
relationships on overall health warrants further investigations.   
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Figure 4.1 Study Design 
 The randomized double-blinded placebo-controlled trial consisted of 4 
arms. Vitamin D insufficient (25(OH)D≤32ng/mL) 60 years of age or older 
individuals were recruited to participant in the 13 week trial. Participants were 
randomized to one of four groups 1) vitamin D supplementation + aerobic 
training, 2) vitamin D supplementation + no aerobic training, 3) placebo + aerobic 
training, 4) placebo + no aerobic training. 
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Table 4.1 Subject Characteristics, Mean±SD   
 
Female 
(n= 12) 
Male 
(n= 12) 
Total 
(n=24) 
Age (years) 68.8±6 65.6±4 67.2±5 
Height (cm) 164.6±5* 177.8±6* 171.2±9 
Weight (kg) 66.4±12* 83.4±14* 74.9±15 
BMI (kg/m2) 24.5±4 26.2±3 25.3±4 
Waist Circumference (cm) 82.9±14* 96.4±11* 89.6±14 
Ethnicity    
White 12 11 23 
African American 0 1 1 
SES (n=24)    
High School Graduate or GED 2 2 4 
Some College, No Degree 0 1 1 
Associates Degree 1 0 1 
Bachelor's Degree 4 2 6 
Master's Degree 2 4 6 
Doctoral Degree 3 3 6 
Income ($; n=21)    
<35,000 2 1 3 
35,000 ≤ 50,000 2 0 2 
50,000 ≤ 100,000 5 4 9 
100,000 ≤ 150,000 1 4 5 
>150000 1 1 2 
*Significant differences between females and males (p<0.05) 
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Table 4.2 EMCL and IMCL Characteristics  
Muscle Lipid Depots Females 
(n=12) 
Males 
(n=12) 
Total 
(n=24) 
IMCL Baseline (au) 0.44±0.28 0.38±0.2 0.41±0.24 
IMCL Endpoint (au) 0.37±0.24 0.34±0.22 0.35±0.22 
EMCL Baseline (%) 26.2±6 26±4 26.1±5 
EMCL Endpoint (%) 25.9±5 25±5 25.4±5 
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Table 4.2 EMCL and IMCL Characteristics 
IMCL and EMCL was not different between males and females. Muscle 
lipid depots at baseline and endpoint were not different in total sample or 
between sexes. 
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Figure 4.2 Relationship between IMCL and age 
 A significant positive linear relationship was observed between IMCL and 
age. The older the participants were the higher their gastrocnemius IMCL 
content.  
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Figure 4.3 The relationship between EMCL, BMI, and waist circumference  
EMCL content was statistically lower in normal weight vs. 
overweight+obese individuals at baseline and at end study (A). EMCL was 
positively correlated with BMI (B) and waist circumference (C).   
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Table 4.3 Variables that predict EMCL 
Predictor Variable  Estimate (Standardized Coefficients (Beta)) p-value 
Moderate Physical Activity 0.055 0.774 
Age -0.048 0.962 
BMI 0.652 0.002 
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Table 4.3 Variables that predict EMCL 
 Age and time spend in moderate activity were not significant predictors of 
EMCL content. Higher BMI levels were a significant predictor of greater EMCL 
content. 
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Table 4.4 Dietary intake between sexes, mean±SD 
 
 Female (n=12) Male (n=12) Total (n=24) 
Energy (kcal) 1510±353* 2055±736* 1782.7±630 
Fat (g) 56.7±19* 82.6±31* 69.7±28 
% Calories from Fat 32±4 34.9±5 33.5±5 
Carbohydrate (g) 185.7±42 245.2±94 215.5±78 
% Calories from 
Carbohydrate  
48.2±6 46.9±7 47.6±7 
Protein (g) 65.1±16 77.3±27 71.2±23 
% Calories from 
Protein 
17.7±4 15.3±3 16.5±4 
*Significant differences between females and males (p<0.05) 
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Table 4.5 Dietary fat intake between sexes, mean±SD 
 Female (n=12) Male (n=12) Total (n=24) 
SFA (g) 18.4±7* 27.7±11* 23±10 
% Calories from SFA 10.3±2 11.8±2 11.1±2 
PUFA (g) 12.9±4* 19.6±9* 16.3  8 
% Calories PUFA  7.3±1 8±2 7.7±2 
MUFA (g) 20.6±7* 28.5±10* 24.6±9 
% Calories MUFA 11.6±2 12.2±2 11.9±2 
PUFA to SFA ratio 0.84±0.3 0.78±0.2 0.81±0.2 
* Significant differences between females and males (p<0.05) 
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Figure 4.4 Relationship between percent calories from fat and EMCL 
 A positive linear relationship was observed between intake of percent 
calories from total fat (A) and saturated fat (B) and EMCL. Individuals with a 
higher consumption saturated and total fat had greater EMCL content.  
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Table 4.6 Variables that predictors of EMCL when adjusting for SFA intake 
Predictor Variable  Estimate (Standardized Coefficients (Beta)) p-value 
Moderate Physical Activity 0.033 0.863 
Age -0.043 0.820 
BMI 0.562 0.009 
% calories from SFA 0.234 0.235 
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Table 4.6 Variables that predictors of EMCL when adjusting for SFA intake 
Age, SFA, and time spend in moderate physical activity were not 
significant predictors of EMCL content. Higher BMI levels were a significant 
predictor of greater EMCL content. 
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Figure 4.5 Relationship between PUFA to SFA Ratio and IMCL  
 A negative linear relationship was observed between an average intake of 
PUFA to SFA and endpoint IMCL measures. Individuals with a higher 
consumption of PUFA relative to SFA intake had lower IMCL content.  
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Table 4.7 Variables that predict IMCL 
Predictor Variable  Estimate (Standardized Coefficients (Beta)) p-value 
Aerobic Training -0.383 0.046 
PUFA:SFA ratio  -0.484 0.014 
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Table 4.7 Variables that predict IMCL 
The stepwise linear regression indicated that aerobic training and greater 
intake of PUFA:SFA significantly predict IMCL content.  
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Figure 4.6 Relationship between PASE questionnaire and local muscle 
hemodynamics 
 A significant negative linear relationship was observed between PASE 
questionnaire scores and rVO2 during (A), 1 minute after (B), and at full recovery 
(C) of the plantar flexion exercise.   
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Chapter 5: General Discussion 
5.1 Discussion 
During the aging process muscle strength and function decline, but 
modifiable lifestyle factors can play a key role in alleviating muscle dysfunction. 
Additionally, age-associated muscle lipid depot changes can negatively affect 
muscle health and function. Higher EMCL content has been associated with 
reduced muscle strength and function in older adults [30, 55]. Likewise, higher 
IMCL content in combination with low IMCL turnover has been linked to greater 
insulin resistance [141]. Dietary intake, vitamin D status, and exercise have been 
associated with muscle lipid depots. Previous work has observed an inverse 
relationship between 25(OH)D concentrations and EMCL [55, 86] and our lab 
has observed a positive linear relationship between 25(OH)D concentrations and 
IMCL in healthy older adults [59]. For our first objective, we examined the 
relationship between muscle lipid depots, vitamin D status, and physical function. 
No significant relationship between 25(OH)D concentrations and IMCL content 
was observed; however, in accordance with previous studies [55, 86] a 
significant negative relationship between EMCL content and 25(OH)D 
concentrations was noted. Further in females, lower EMCL content and higher 
25(OH)D concentrations were significant predictors of faster FSST times 
independent of age and BMI. These observational data suggest that maintaining 
higher vitamin D status may play a role in lowering EMCL and positively 
impacting physical function.  
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Exercise can positively influence overall muscle health by lowering EMCL 
content and increasing IMCL turnover [30, 141]. Previous studies have observed 
muscle lipid depots changes in younger and older adults enrolled in an exercise 
intervention [44, 74, 77, 95]. However, we aimed to examine the relationship 
between daily physical activity levels and muscle lipid depots. We used multiple 
methods to measure physical activity levels and no relationship was observed 
between physical activity and muscle lipid depots. These results may suggest 
that increased daily physical activity alone may not be enough to contribute to 
healthful alteration in muscle lipid depots. Higher-intensity, structured exercise 
regimens may be necessary to alter muscle lipid depots. However, the 
relationship between physical activity and muscle lipid depots warrants further 
investigation, as our sample was relatively small and lacked variance in physical 
activity levels.   
Similar to vitamin D and physical activity, BMI is another modifiable 
lifestyle factor that can influence muscle lipid depots. Previous studies observed 
a relationship between higher BMI categories and greater IMCL and EMCL 
content [79, 84]. Also, greater BMI has been associated with lower vitamin D 
status [39, 43]. We further assessed these relationships in a cohort of adults 60 
years of age or older. Although our findings were not significant, we observed 
increases in muscle lipid depots with increases in BMI category. We observed 
lower vitamin D status in higher BMI categories and a significant negative 
correlation between 25(OH)D concentrations and central adiposity measured by 
waist circumference. We observed a positive relationship between EMCL and 
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BMI in the cohort enrolled in the randomized double-blinded placebo-controlled 
trial. BMI was also a significant predictor of EMCL when adjusting for physical 
activity levels and age. Together these data suggest that without exercise, higher 
BMI and central adiposity, relate to muscle lipid depots accumulation and may 
potentially leave higher BMI individuals more susceptible to lower vitamin D 
status.  
In addition to the aforementioned modifiable lifestyle factors, dietary intake 
can influence muscle lipid depots. We retrospectively analyzed the relationship 
between dietary intake and muscle lipid depots in participants enrolled in a 
double-blinded randomized controlled-trial. Ectopic fat accumulation was 
observed in skeletal muscle of individuals with an overweight or obese BMI 
classification [30]. In addition, changes in fat distribution, independent of body 
weight and waist circumference, occur with aging with increased fat deposition 
seen in the skeletal muscle [154]. Increases in fat storage, decline in 
mitochondria content and function, and poor capacity for oxidative metabolism 
leaves older adults susceptible to increased EMCL content and stagnant IMCL 
content [72, 74, 77].  
Adding to previous findings [30], we observed a positive relationship 
between increased EMCL and dietary fat intake. Also for the first time to our 
knowledge, a relationship between increased PUFA:SFA dietary intake and 
decreased IMCL was observed. Further, the aerobic training program and 
increased dietary intake of PUFA:SFA were the best predictors of IMCL. Both 
human and animal dietary intervention trials have observed a relationship 
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between greater unsaturated fatty acids and higher IMCL turnover [84, 88, 89]. 
Combining our data with previous findings, these results may suggest that 
individuals that consume a higher unsaturated fatty acid diet in combination with 
aerobic exercise, may have lower lipid accumulation potentially due to greater 
lipid turnover.  
We did not assess lipid turnover, but we used NIRS/DCS measures to 
monitor microvascular hemodynamic changes during a foot plantar flexion 
exercise this provided us with an index to monitor local muscle tissue 
hemodynamics. Individuals that reported engaging in more physical activity had 
lower rBF and rVO2 during and after the foot plantar flexion exercise. These 
findings may due to active individuals being more acclimated to increases in 
muscle demand and therefore having a relatively lower hemodynamic response 
compared with less active individuals. This would suggest that greater physical 
activity levels and not necessarily exercise may help to prevent microvascular 
dysfunction that occurs naturally with aging. 
5.2 Limitations 
A major limitation of this dissertation was the nature of a retrospective 
study analysis. A retrospective study uses data that has previously been 
documented and may not be related to the research aims [155]. The first specific 
aim, used combined datasets from 3 different trials. Participants were recruited 
over a 4 year period and completed varied study measures. Incomplete data was 
inevitable, as waist circumference, DXA, CT, and FSST measures were not 
completed for each individual trial. Also, physical activity levels were difficult to 
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compare across the total sample as diverse assessment methods were 
implemented to measure physical activity levels. Physical activity levels were 
measured either by using a physical activity questionnaire, accelerometry wear, 
or PASE questionnaire. Although the physical activity questionnaire inquired 
about frequency, duration, and intensity of exercise the nature of an open-ended 
question may have led to varied subjective responses. For example, one 
question inquired if participants exercised and if so to provide additional detail. 
This type of open-ended question allowed for individuals’ to subjectively 
determine whether their activities constituted as exercise or physical activities of 
daily living.  
A major limitation in both aims was that the data was underpowered for 
some variables due to the small sample size. Between both aims and generally 
among the literature racial diversity is lacking. Our study participants were 
primarily White and since genetic factors may play a role in the interpretation of 
vitamin D status there is a need to investigate these relationships in all races. 
Further, currently no gold standard exists for the analysis and reporting of IMCL 
and EMCL, therefore muscle lipid depots can be difficult to review across studies. 
5.3 Significance and Implications 
The findings from both aims support previous literature and provide new 
information about the relationship between modifiable lifestyle factors and muscle 
lipid depots in older adults. First, we were able to provide further evidence for the 
associations between 25(OH)D concentrations, EMCL, and physical function. 
Although not significant, similar to previous findings we observed a relationship 
164 
between increased muscle lipid depots and BMI categories. Decreased 25(OH)D 
concentrations in higher BMI categories provide further evidence to the 
established relationship. In both animal and human models, studies have 
focused on dietary fat interventions with varied fat composition and study 
duration. The novelty of our findings was that we examined the relationship 
between muscle lipid and daily dietary habits. Even without any supplemental 
dietary intervention, we observed that higher IMCL was related with increased 
daily intake of PUFA:SFA. In combination, a higher daily unsaturated fatty acid 
diet and exercise were significant predictors of IMCL content, which was 
consistent with previous work that examined dietary and exercise interventions 
on IMCL turnover.  
With observational retrospective data, we were able to provide information 
about the relationships between our variables. Future intervention trials are 
needed to examine the cause and effect between modifiable lifestyle factors and 
muscle lipid depots in older adults. Further, both animal and human studies need 
to focus on identifying mechanisms related to how modifiable lifestyles factors 
may cause favorable lipid changes (EMCL decreases and increased IMCL 
turnover). 
5.4 Future Directions 
The findings from our study demonstrate that modifiable lifestyles factors 
relate with age-associated alterations in muscle lipid depots. However, as our 
results were observational in nature, future studies should consider a more 
robust study design aimed to examine the effect of lifestyles factors on 
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deleterious muscle lipid accumulation. Further, studies should be appropriately 
powered and include both females and males of varied age and diverse races.   
The discrepancy between our previous work [59] and our current findings 
regarding IMCL and 25(OH)D concentrations warrant further investigation. Future 
studies should examine the effect of vitamin D supplementation in vitamin D 
deficient older adults on muscle lipid depots changes and physical function. Due 
to the dynamic nature of IMCL, it is important to measure muscle lipid turnover 
and mitochondrial function as well as IMCL quantity. Further, multiple physical 
function measures should be completed in order to provide a comprehensive 
approach to assess muscle strength and performance. It is also important to 
discern between daily physical activity and structured exercise and the role 
physical activity may play on age-associated muscle lipid depots. Less active 
older populations may be more receptive and compliant to meeting physical 
activity goals compared with initiating and maintaining a rigorous exercise 
regimen. Therefore, the effect of physical activity on muscle lipid depots needs to 
be further investigated. 
Dietary intake should also be considered when assessing muscle lipid 
depots. Unsaturated fatty acids seem to have a favorable effect on muscle lipid 
depots and turnover; however human dietary fat interventions are necessary to 
examine the effect of a high unsaturated fatty acid diet on muscle lipid depot 
changes and overall health. Finally, with aging microvascular changes were 
observed and future studies should incorporate novel techniques, such as 
NIRS/DCS, to assess the effect of modifiable lifestyle factors on local muscle 
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tissue changes. Taken together, our findings show that modifiable lifestyles 
factors (BMI, vitamin status, physical activity, and dietary fat intake) relate with 
muscle lipid metabolism and may contribute to overall health and quality of life in 
older adults. 
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Appendices 
A.1 MRI Screening Form for Participants 
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A.2 NIRS/DCS formulas 
NIRS for oxygenation measurement: 
Total hemoglobin concentrations [tHb]: [tHb] = [HbO2] + [Hb] 
Tissue blood oxygen saturation (StO2): StO2 = 100% x ([HbO2]/[tHb]) 
DCS for blood flow measurement: 
Relative blood flow (rBF): rBF = (BFI)/(BFIbaseline) 
Hybrid NIRS/DCS measurement: 
(1) VO2 = BF x ([O2]a – [O2]v) 
(2) OEF = ([O2]a – [O2]v)/[O2]a 
(3) combining equation (1) and (2): VO2 = OEF x BF x ([O2]a) 
(4) relative change (rVO2, rOEF, rBF, (r[O2]a)) can be determined by dividing the 
baseline value: rVO2 = rOEF x rBF x (r[O2]a) 
(5) assuming [O2]a is constant: rVO2 = rOEF x rBF  
(6) OEF = (SaO2 – StO2)/(γ x SaO2) 
(7) assuming γ is constant and SaO2 is constant at 100%: 
rOEF = (1 – StO2) / (1 – StO2 baseline) 
(8) rVO2 = rBF x (1 – StO2) / (1 – StO2 baseline) 
Abbreviation 
BFI Blood flow index 
[O2]a Arterial oxygen concentration  
[O2]v Venous oxygen concentration 
OEF Oxygen extraction fraction 
VO2 Oxygen consumption rate 
γ % of blood volume contained in the venous compartment of 
the vascular system 
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A.3 Medical History Questionnaire 
 
YES NO 1. Is your doctor currently prescribing drugs (for example, 
water pills) for your blood pressure, heart, or any other 
condition? 
 
  Medicines/dosage:                                                                    
Taken For: 
   
   
   
YES NO 2. Do you know of any other reason (such as any 
neuromuscular or metabolic disorders, eg diabetes, 
breathing issues, asthma or  emphysema) why you 
should not do physical activity? 
  List: 
   
   
   
   
YES NO 3. Are you currently seeing your doctor or health care 
provider for any reason? If yes, please explain any 
findings (heart murmur, abnormal pulmonary findings 
etc): 
  List: 
   
   
   
   
YES NO 4. Do you currently smoke (or have a history of smoking) or 
use tobacco products?  When did you last quit? 
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YES NO 5. Is there any family history of pulmonary, metabolic 
disease,   stroke, or sudden death?  
  If yes, please list: 
   
   
   
   
YES NO 6. Any other known allergies (medications, food, latex, etc) 
  If yes, please list: 
   
   
   
   
YES NO 7. Do you have any chronic illnesses or known viruses 
(hepatitis, HIV) etc? 
 
  If yes, please explain: 
   
   
   
   
YES NO 8. Have you had any surgeries of any kind? 
    
  If yes, please list type, reason and year: 
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YES NO 9. Are you taking any over the counter medications, dietary         
supplements (vitamins or minerals (multivitamins)? 
  Please list both type/dosage and reason for taking 
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A.4 Physical Activity Readiness questionnaire (PAR-Q) 
 
Common sense is your best guide when you answer these questions. Please 
read the questions carefully and answer each one honestly; circle YES or NO. 
 
YES NO 1. Has your doctor ever said that you have a heart 
condition/high blood pressure and that you should 
only do physical activity recommended by a doctor? 
YES NO 2. Do you feel pain (tingling, heaviness, burning, 
tightness, squeezing) in your chest when you do 
physical activity? 
  List any heart condition here: 
__________________________________________ 
 
YES NO 3. In the past month, have you had chest pain when 
you were not doing physical activity? 
YES NO 4. Do you lose your balance because of dizziness or 
do you ever lose consciousness? 
YES NO 5. Do you have an orthopedic (bone or joint) problems 
that could be made worse by a change in your 
physical activity? 
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A.5 AHA/ACSM Health/Fitness Screening Questionnaire 
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A.6 Physical Activity Questionnaire 
In terms of physical demands, 
how would you rate your 
lifestyle? 
 
  Sedentary 
  Slightly Active 
  Active 
  Very Active 
 
 
In terms of physical or muscular 
demands, how would you rate 
your workplace? 
 
  Sedentary 
  Slightly Active 
  Active 
  Very Active 
  Not Applicable 
 
 
Are you currently exercising?   YES 
  NO 
 
 
What type of exercise do you 
participate in regularly? 
  Resistance 
  Cardio 
  Resistance and Cardio 
 
 
How many times per week do 
you participate in these types of 
exercise? 
 
 
If resistance training, please 
briefly describe your typical 
workout (full body, one muscle 
group per day, intensity, 
duration etc): 
 
 
Please list any other activities 
below: 
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A.7 GXT Data Collection Form 
Subject id:    Date: 
Resting Data: 
HR BP Angina? 
   
Graded Exercise Testing 
Stage Workload 
Speed/Incline 
Min HR BP RPE 
Chest/Legs/Overall 
Angina? 
1 2.2 0% 0-2       
2 2.6 0% 2-4       
3 3.0 2 4-6       
4 3.4 4 6-8       
5 3.8 6 8-10       
6 4.2 8 10-12       
7 4.6 10 12-14       
8 5.0 12 14-16       
9 5.4 14 16-18       
10 5.8 16 18-20       
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Recovery 
Workload 
Speed/Incline 
Min HR BP Angina? 
0 0% 1    
0 0% 3    
0 0% 5    
 
Notes: 
Form completed by:____________________ 
Testing completed by:___________________ 
Notes:_________________________________________________________ 
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A.8 Aerobic Training Data Collection Form 
 
Subject Id:  Date/Time:   
Session:    
Weight:    
Target heart rate:    
Study personnel:    
 
BP before AT:  BP after AT:  
HR before AT:  HR after AT:  
 
Min Workload 
Speed/Incline 
Average 
HR 
Comments 
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